Your browser is no longer supported. Please, upgrade your browser.
IWM iShares Russell 2000 daily Stock Chart
iShares Russell 2000
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.56%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month7.84%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter8.23%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.95 Perf Half Y18.59%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year0.57%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range92.85 - 121.75 Perf YTD8.42%
Dividend1.76 P/FCF- EPS past 5Y- ROI- 52W High-0.56% Beta-
Dividend %1.45% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low30.39% ATR1.60
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)64.04 Volatility0.88% 1.15%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.04 Prev Close120.83
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume29.15M Price121.07
Recom- SMA202.37% SMA504.90% SMA2009.61% Volume30,179,496 Change0.20%
Jul-29-16 04:35PM  Stock Market Video Analysis 7/29/16
Jul-28-16 06:34PM  Super-Hot July Market Election Handicapping
02:25PM  Crash Is Coming, and Smart Money, Insiders Are Leaving the Market
01:40PM  Over The Past 50 Years An Earnings Recession Of This Magnitude Has Never Failed To Trigger A Bear Market
10:37AM  Good Vibes for Diversified Small-Cap ETFs
07:00AM  Trader's Daily Notebook: This Is Impressive. Annoying, but Impressive.
Jul-27-16 08:25AM  Small-Cap ETFs Are Taking the Lead
07:20AM  Trader's Daily Notebook: Watching the Paint Dry
Jul-26-16 04:21PM  August, a month of pops and drops
12:50PM  Bull trend intact, S&P 500 stages garden-variety pullback at MarketWatch
11:05AM  How Has Lower Nominal GDP Growth Affected Yields?
07:00AM  Trader's Daily Notebook: To Make Progress We Could Use Excess, Not This Mess
Jul-25-16 05:02PM  Hot July Markets & Late-Summer/Autumn Buying Opportunities
02:38PM  Investors Are Relying On Dangerous Rationalizations That Have Never Held True In The Past
09:49AM  Index ETF Flows: High Beta, Low Benefits
07:00AM  Traders Daily Notebook: Back and Looking for a Push
Jul-23-16 11:01AM  The Week Ahead: Breakout Or Fake Out? at Forbes
08:01AM  What to expect from the stock market this week
12:01AM  [$$] Profiting From Battling Bulls and Bears at
Jul-22-16 04:57PM  Housing and Jobs Keep U.S. Indexes Near Highs at Investopedia
04:38PM  Stock Market Video - Uptrend Continues..
04:29PM  New 3 Peaks & Last Chance 2 Free Almanacs
07:00AM  Trader's Daily Notebook: Demand May Finally Be Weakening
Jul-21-16 07:15AM  Next Up: The Russell 2000
02:06AM  Will the Rise in US Retail Sales Improve Consumer Spending?
Jul-20-16 02:41PM  As Markets Rally, Fund Managers Go Underweight Equities For The First Time in 4 Years
02:13PM  4 ways to protect yourself from Americas retirement savings crisis
01:10PM  Russell-2000 Set to Outperform Blue Chips at Investopedia
12:22PM  In Retrospect: How the 2008 Crisis Affected SPYs Valuation
11:13AM  Equity Valuation Fell by 47% When the Dot-Com Bubble Burst
Jul-19-16 04:45PM  There Has Never Been A Better Time To Be An Active (Thinking) Investor
02:24PM  Inside Bill Ackmans Stance on Mondelez
02:24PM  Inside Bill Ackmans Current Stance and View of His Holdings
12:24PM  361 Capital Weekly Research Briefing: Invincible, Indomitable, Unbeatable?
Jul-18-16 07:46PM  2007 Revisited: Is This Bull Is Running On Fumes?
12:42PM  Index ETFs: Inflows Support US Equity Rally
10:40AM  Shorts Still Clinging To Mid-Cap ETFs
10:07AM  How Tesla Scores and Can Deliver, According to Damodaran
07:00AM  Trader's Daily Notebook: Bullish Trend Remains Strong
Jul-17-16 10:16AM  Whats Next For Central Planners And Their Kale Smoothie Economy?
Jul-16-16 11:35AM  The Week Ahead: Smart Money Buying Or Is It A Conspiracy? at Forbes
08:01AM  What to expect from the stock market this week
Jul-15-16 08:36PM  Five Charts To Watch Next Week at Forbes
06:05PM  Where Does This Leave Investors?
05:46PM  Historically, new all-time S&P 500 high doesnt guarantee further gains
04:49PM  Markets Reach New Highs as Brexit is Left Behind at Investopedia
04:38PM  Stock Market Video Analysis 7/15/16
02:37PM  287,000 Jobs Arent Enough: Why the Job Market Faces Challenges
10:31AM  Valuation Expert Aswath Damodaran Weighs in on Teslas Stock
10:05AM  Why Monetary Stimulus Is Proving Less Effective
07:00AM  Trader's Daily Notebook: Dull, Dull, Dull
Jul-14-16 08:37PM  Two Reasons Brexit Could Be A Huge Positive For The Global Economy at Forbes
05:10PM  Stimulus assurances fuel hot July
11:30AM  Are US Stocks Expensive?
11:30AM  You Are Living in a Low-Return Environment
11:06AM  Bill Gross: Possibility of Deglobalization in the Economy
09:06AM  Bill Gross: Whats His New Normal Thesis?
08:58AM  This is what stocks need to really get the party going at MarketWatch
07:00AM  Trader's Daily Notebook: There's a Break in the Action
Jul-13-16 08:13PM  Do Record Low Yields And Record High Stocks Spell Trouble? at Forbes
05:22PM  Small stocks to signal big gains?
04:06PM  Inverted head-and-shoulders pattern in small-caps sounds a bullish signal at MarketWatch
11:08AM  Lower Rates Arent Equating to Higher Equity Prices
10:04AM  Key ADP Report Highlights: 172,000 New Jobs in June
09:07AM  Will June Jobs Report Speed Up the Feds Next Rate Hike?
07:30AM  Stocks are back at all-time highs, but markets are still trading as if we're in a crisis
07:00AM  Trader's Daily Notebook: Can We Get Some Consolidation Around Here?
07:00AM  Index Construction Matters at Morningstar
Jul-12-16 06:00PM  If This Happens, Stocks Could Take A Serious Leg Higher
05:47PM  Stocks Can Go Much Higher From Here at Forbes
07:45AM  Bill Gross: Credit Is the Oil That Lubes the System
07:45AM  Bill Gross: The Economy Needs Credit Creation to Multiply Growth
Jul-11-16 05:44PM  S&P 500 defies the odds with new all-time high
04:16PM  Stocks And Bonds Both Testing Key Areas
12:55PM  We Are Witnessing The Greatest Dichotomy In The History Of Financial Markets
10:42AM  Inklings of a Breakout for Small-Cap ETFs
09:24AM  The Bull Isn't Done: Dow Industrials and S&P 500 Near All-time Highs
01:00AM  Bristol-Myers Squibb, Radian and SPDR S&P 500 ETF: Doug Kass' Views
Jul-10-16 11:25PM  The Most Important Thing For A Trader
Jul-09-16 10:56AM  The Week Ahead: What Are Those Bear Market Forecaster's Missing? at Forbes
08:01AM  What to expect from the stock market this week
07:31AM  Was The 52-Week High Worth The Wait?
07:05AM  Are Stocks Ready To Rocket Higher?
Jul-08-16 09:00PM  Twitter Makes a Move; the Market Is Overvalued: Best of Kass
05:10PM  Stocks Continue Winning Streak After Payroll Data at Investopedia
04:37PM  52 Week High for S&P 500
03:20PM  Julys Typical Trading Pattern Last 21-Years
12:23PM  Event-Driven Strategy in a Volatile Market
12:22PM  Commodity Trading Advisors Outperformed in June: Is It a Trend?
Jul-07-16 05:32PM  S&P 500 Tends to Melt Second Half July
12:41PM  Smaller-Cap ETFs Cling To Gains As Oil Reversal Sends Indexes Lower
09:07AM  Will the US Presidential Election Affect Economic Growth?
09:07AM  Has Britain Really Voted Its Way to Prosperity?
Jul-06-16 10:13PM  2016 Second Half Outlook
09:47AM  Good-Bye to SPY? Not So Fast!
Jul-05-16 07:02PM  Filings Show Big Investors Taking Advantage Of Dip In Stocks at Forbes
05:59PM  Final Trade: IWM, SAVE, SLV & GIS
03:54PM  Trump and Soros Expected a Brexit, Jeffrey Gundlach Did Not
12:18PM  Potential Repeat Pattern Suggests Bear Legs at Forbes
05:00AM  How The 3 Most Heavily Traded ETFs Are Faring: Impressive Recovery
The investment seeks to track the investment results of the Russell 2000 Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
DHR Danaher Corp. daily Stock Chart
Danaher Corp.
IndexS&P 500 P/E20.28 EPS (ttm)4.02 Insider Own0.20% Shs Outstand689.12M Perf Week0.25%
Market Cap56.12B Forward P/E21.08 EPS next Y3.86 Insider Trans-23.45% Shs Float604.20M Perf Month7.30%
Income2.80B PEG14.48 EPS next Q1.22 Inst Own78.90% Short Float1.14% Perf Quarter11.21%
Sales21.26B P/S2.64 EPS this Y3.30% Inst Trans0.07% Short Ratio1.84 Perf Half Y24.38%
Book/sh35.59 P/B2.29 EPS next Y-9.87% ROA- Target Price87.69 Perf Year17.69%
Cash/sh0.96 P/C84.48 EPS next 5Y1.40% ROE- 52W Range61.40 - 82.19 Perf YTD16.04%
Dividend0.64 P/FCF- EPS past 5Y7.70% ROI7.50% 52W High-0.91% Beta1.14
Dividend %0.79% Quick Ratio1.00 Sales past 5Y10.40% Gross Margin52.50% 52W Low32.65% ATR0.95
Employees81000 Current Ratio1.50 Sales Q/Q14.80% Oper. Margin- RSI (14)68.43 Volatility0.98% 1.21%
OptionableYes Debt/Eq0.51 EPS Q/Q40.10% Profit Margin- Rel Volume0.92 Prev Close81.18
ShortableYes LT Debt/Eq0.50 EarningsJul 25 BMO Payout- Avg Volume3.74M Price81.44
Recom1.80 SMA201.16% SMA505.54% SMA20013.84% Volume3,428,528 Change0.32%
Jul-11-16Reiterated Barclays Overweight $105 → $86
Jul-05-16Initiated Goldman Neutral
Jun-24-16Upgrade Bernstein Mkt Perform → Outperform
May-27-16Reiterated RBC Capital Mkts Sector Perform $96 → $99
Apr-22-16Reiterated Stifel Buy $109 → $110
Apr-22-16Reiterated RBC Capital Mkts Sector Perform $87 → $96
Apr-22-16Reiterated Barclays Overweight $104 → $105
Apr-18-16Reiterated Barclays Overweight $99 → $104
Apr-04-16Downgrade Bernstein Outperform → Mkt Perform
Jan-27-16Reiterated RBC Capital Mkts Sector Perform $93 → $87
Dec-08-15Downgrade Goldman Buy → Neutral
Oct-26-15Reiterated Argus Buy $98 → $104
Oct-23-15Reiterated Stifel Buy $98 → $103
Oct-23-15Reiterated RBC Capital Mkts Sector Perform $91 → $92
Oct-23-15Reiterated Barclays Overweight $89 → $94
Oct-01-15Reiterated Stifel Buy $100 → $98
Sep-30-15Initiated Leerink Partners Outperform
Sep-09-15Reiterated RBC Capital Mkts Sector Perform $93 → $91
Sep-09-15Initiated Sterne Agee CRT Neutral
Jul-28-15Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-29-16 11:06AM  Why Roper Technologies 1H16 Operating Cash Flows Declined
Jul-28-16 02:50PM  [$$] Cray, NetScout Ready to Rise at
01:04PM  DANAHER CORP /DE/ Financials
Jul-26-16 03:31PM  Dovers Earnings Plummet on Low Energy Earnings
11:48AM  How Do We Deal With This Stabilization?
Jul-25-16 02:51PM  [$$] Danaher Earnings Top Views at The Wall Street Journal
01:07PM  Edited Transcript of DHR earnings conference call or presentation 25-Jul-16 12:00pm GMT
10:36AM  Why Traders Are Watching Tesla, SolarCity, Allergan & Other Stocks Today at Insider Monkey
10:01AM  U.S. stocks retreat from records as investors sift earnings deluge at MarketWatch
10:00AM  Danaher (DHR) Beats on Q2 Earnings, Guidance Lowered
09:05AM  Danaher (DHR) Stock Gains on Q2 Earnings Beat
07:51AM  Danaher Delivers Better Than Expected Q2 Earnings
07:45AM  Danaher (DHR) Beats Q2 Earnings, Lags Revenues
07:07AM  Q2 2016 Danaher Corp Earnings Release - 06:00 am ET
06:16AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financ
06:11AM  DANAHER CORP /DE/ Files SEC form 10-Q, Quarterly Report
06:09AM  Danaher beats 2Q profit forecasts
06:01AM  Danaher Reports Second Quarter 2016 Results PR Newswire
Jul-22-16 06:17PM  Cramers earnings approach: Buy at the end of the week, not the beginning at CNBC
02:48PM  Danaher (DHR) Stock Slips Ahead of Q2 Earnings Report
10:19AM  2 Conglomerates' Earnings to Watch on Jul 25: DHR, CR
09:16AM  Danaher attracts another upside position
Jul-21-16 01:47PM  Danaher Corporation -- Moody's affirms A2 unsecured rating of Danaher; outlook to stable at Moody's
08:24AM  Danaher (DHR) Q2 Earnings: Stock Likely to Disappoint?
Jul-19-16 12:17PM  ETFs with exposure to Danaher Corp. : July 19, 2016
Jul-18-16 07:27PM  Cramer: This battleground stock defies current wisdom at CNBC
05:05PM  With Danaher Spinoff Transaction Complete, Trifecta Stocks Exit Position With Profit
12:12PM  Ecolab Invests in Aquatech International to Improve Processes
Jul-15-16 03:51PM  Danaher To Redeem Senior Notes
11:01AM  [$$] Top Picks in Financial Technology at
09:29AM  Danaher Corporation To Redeem Senior Notes PR Newswire
08:50AM  What Falling Estimates & Price Mean for Danaher (DHR)
Jul-14-16 04:31PM  DANAHER CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
Jul-13-16 06:14PM  Deutsche Bank Shuffles M&A Ranks; Ratigan to Leave at The Wall Street Journal
10:39AM  General Electric: Brexit Proof? at
10:16AM  Danaher (DHR) Stock Rising, Jefferies Drops Price Target
Jul-11-16 05:17PM  What Will Hillary Clinton's Plan Do For Medical Hardware Stocks?
Jul-08-16 06:04AM  DANAHER CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispos
Jul-07-16 08:05AM  Danaher Offers Safety but Also Growth for Investors
Jul-06-16 09:59AM  Fortive (FTV) Stock Down, Barclays Initiates Coverage after Danaher Split
Jul-05-16 08:28PM  Fortive starts trading, becomes one of Washington state's largest publicly traded companies at
04:34PM  Danaher (DHR) Stock Tumbled on Heavy Volume After Completing Fortive Spin-Off
08:53AM  Danaher Completes Fortive Spin-Off, Trading to Begin Today
07:28AM  Coverage initiated on Danaher by Goldman
05:00AM  Billionaire Brothers Seek to Copy Danaher M&A-Fueled Ascent at Bloomberg
Jul-02-16 12:01AM  Danaher Corporation Completes Separation of Fortive Corporation PR Newswire
Jun-30-16 11:15AM  Trader sees little downside in Danaher
Jun-28-16 12:09PM  Danaher Corp. :DHR-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016
08:34AM  Danaher Corp. breached its 50 day moving average in a Bearish Manner : DHR-US : June 28, 2016
Jun-27-16 07:25AM  Buy These 5 Big Stocks to Recoup Post-Brexit Declines
Jun-24-16 03:24PM  Industrial Stocks: Brexit is 'Bad For All Our Companies' at
01:29PM  Danaher (DHR) Stock Falls, Bernstein Upgrades
07:43AM  Early movers: RBS, CS, NEM, XOM, MRO, XRX, FINL & more at CNBC
Jun-23-16 06:00PM  Danaher Schedules Second Quarter 2016 Earnings Conference Call PR Newswire
05:46PM  Albemarle and Fortive Set to Join the S&P 500; EMCOR to Join S&P MidCap 400; Inteliquent to Join S&P SmallCap 600 PR Newswire
Jun-22-16 06:00AM  Jim Cramer's Top Takeaways: Polaris, Thor, Danaher
Jun-21-16 05:22PM  DANAHER CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obli
06:00AM  Fortive Announces Equity Investor Meetings For Upcoming Spin-off From Danaher And Provides Financial Outlook As Standalone Company PR Newswire
Jun-20-16 08:10AM  Danaher Corp. moving forward with corporate split at
Jun-13-16 11:17AM  Danaher And Fortive Take First Steps As Separate Companies at
Jun-09-16 04:39PM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:15PM  Fortive Prices Private Offering of Additional 4.300% Senior Notes due 2046 PR Newswire
10:25AM  Fortive Announces Private Offering of Additional 4.300% Senior Notes due 2046 PR Newswire
Jun-08-16 12:43PM  [$$] Danaher: Rock Solid Growth; Cut-Rate Price at
Jun-07-16 07:05AM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:30AM  Here's who made the Fortune 500 from Greater Washington at
Jun-06-16 06:32PM  Fortive Prices Private Offering of Senior Notes PR Newswire
04:32PM  Fortive Corporation -- Moody's assigns Baa1 Senior Unsecured Rating to Fortive; stable outlook at Moody's
09:06AM  Fortive Announces Private Offering of Senior Notes PR Newswire
Jun-03-16 05:45PM  The Economy is A Mosaic - S&P 500 Intrinsic Value Update
Jun-02-16 04:15PM  Danaher To Present At Goldman Sachs Global Healthcare Conference PR Newswire
11:48AM  Charlotte-based Jeld-Wen files to go public at
Jun-01-16 04:17PM  DANAHER CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements a
04:15PM  Danaher Declares Pro Rata Dividend Of Fortive Common Stock And Announces Expected "When-Issued" Trading Of Fortive Common Stock PR Newswire
May-30-16 02:31PM  Five Capital Goods Stocks Hedge Funds Are Betting On at Insider Monkey
May-25-16 06:00PM  Danaher To Present At Bernstein Strategic Decisions Conference PR Newswire
May-23-16 06:01PM  ROIC: Reinvestment vs Legacy Moats [ANALYSIS]
May-20-16 05:55PM  Fortive Form 10 Registration Statement Declared Effective PR Newswire
May-19-16 05:00PM  Danaher And Fortive To Webcast Investor And Analyst Event PR Newswire
May-15-16 12:32PM  Impax Asset Management Is Betting Heavily on Water Stocks at Insider Monkey
May-12-16 05:00PM  Danaher To Present At Electrical Products Group Conference PR Newswire
04:42PM  ETFs with exposure to Danaher Corp. : May 12, 2016
07:58AM  DANAHER CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-10-16 04:15PM  Danaher Announces Quarterly Dividend PR Newswire
04:03PM  Danaher Is Breaking Out on the Upside at TheStreet
04:03PM  Danaher Is Breaking Out on the Upside
May-09-16 03:21PM  Ecolab Announces Its Dividend and 1Q16 Results: Whats to Come?
May-05-16 01:22AM  PRWCX: T Rowe Price Capital Appreciation Fund Top 5 Holdings Analysis at Investopedia
May-04-16 06:46AM  Danaher Announces Anticipated Fortive Separation Date PR Newswire
May-02-16 04:19PM  Tuesday's Earnings on Deck at TheStreet
Apr-29-16 05:45PM  Tech Leaders List Debuts In Tough Market Environment at Investor's Business Daily
Apr-27-16 12:30PM  ETFs with exposure to Danaher Corp. : April 27, 2016 at Capital Cube
Apr-26-16 10:24AM  Danaher Corp. :DHR-US: Earnings Analysis: Q4, 2015 By the Numbers at Capital Cube
Apr-25-16 09:45AM  Why Did Dover Stock Fall after 1Q16 Earnings Release? Market Realist
Apr-21-16 04:20PM  Edited Transcript of DHR earnings conference call or presentation 21-Apr-16 12:00pm GMT Thomson Reuters StreetEvents
02:50PM  Danaher Got the Job Done, Now What? at Bloomberg
11:09AM  Danaher (DHR) Beats on Q1 Earnings & Sales, Raises View Zacks
10:48AM  Keywords and guidance point to better earnings at CNBC
07:34AM  Danaher (DHR) Beats on Both Q1 Earnings & Revenues Zacks
07:07AM  Q1 2016 Danaher Corp Earnings Release - 06:00 am ET CCBN
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Its Test & Measurement segment provides instruments products; services and products that help to convert concepts into finished products; professional tools; and wheel service equipment. The company's Environmental segment provides instrumentation and disinfection systems; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale and payment system, environmental compliance, vehicle tracking, and fleet management. Its Life Sciences & Diagnostics segment offers chemistry systems, immunoassay systems, hematology and flow cytometry products, microbiology systems, and systems and workflow automations solutions. This segment also provides professional microscopes; mass spectrometers; bioanalytical measurement systems; workflow instruments and consumables; and filtration products, which are used to remove solid, liquid, and gaseous contaminants. The company's Dental segment offers consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. The company's Industrial Technologies segment provides equipment, consumables, and software for various printing, marking, coding, packaging, design, and color management applications; and a range of electromechanical and electronic motion control products. This segment also offers devices that sense, monitor and control operational or manufacturing variables; instruments, controls, and monitoring systems used in electric utilities and industrial facilities; engineered energetic materials components; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COMAS DANIEL LEVP & CFOJul 27Option Exercise22.2696,4462,147,333259,270Jul 29 07:56 AM
COMAS DANIEL LEVP & CFOJul 27Sale80.8896,4467,800,332189,270Jul 29 07:56 AM
HEFNER LINDA PDirectorJul 11Option Exercise23.8810,578252,60320,197Jul 12 04:54 PM
Lalor Angela SSVP, Human ResourcesMay 12Sale97.778,392820,46148,110May 13 08:41 AM
SCHWIETERS JOHN TDirectorMay 06Option Exercise31.578,000252,56026,958May 09 05:36 PM
LICO JAMES AExecutive Vice PresidentApr 27Option Exercise37.7540,0001,510,000181,517Apr 29 07:27 AM
LICO JAMES AExecutive Vice PresidentApr 27Sale96.9358,9545,714,495122,563Apr 29 07:27 AM
Raskas DanielSVP-Corporate DevelopmentApr 22Option Exercise37.0724,300900,80141,524Apr 26 05:03 PM
COMAS DANIEL LEVP & CFOApr 22Option Exercise37.7589,2803,370,320230,978Apr 26 05:04 PM
DANIEL WILLIAM KEVPApr 22Option Exercise39.8226,1401,040,895164,785Apr 26 05:03 PM
Joyce Thomas Patrick JRPresident and CEOApr 22Sale95.5014,6301,397,165137,246Apr 26 05:04 PM
King WilliamSenior Vice PresidentApr 22Sale96.316,000577,86017,386Apr 26 05:02 PM
Raskas DanielSVP-Corporate DevelopmentApr 22Sale95.9524,3002,331,58517,224Apr 26 05:03 PM
DANIEL WILLIAM KEVPApr 22Sale96.0641,1403,952,086123,645Apr 26 05:03 PM
COMAS DANIEL LEVP & CFOApr 22Sale95.7189,2808,545,015141,698Apr 26 05:04 PM
LICO JAMES AExecutive Vice PresidentFeb 29Option Exercise37.2460,0002,234,155186,878Mar 01 05:56 PM
LICO JAMES AExecutive Vice PresidentFeb 29Sale89.2460,0005,354,348141,517Mar 01 05:56 PM
LOHR WALTER GDirectorFeb 26Option Exercise31.578,000252,560461,505Feb 29 05:48 PM
Raskas DanielSVP-Corporate DevelopmentFeb 26Sale89.004,656414,38417,786Feb 29 05:48 PM
LOHR WALTER GDirectorFeb 26Sale89.068,000712,440453,505Feb 29 05:48 PM
EHRLICH DONALD JDirectorFeb 10Option Exercise31.578,000252,56077,905Feb 11 05:46 PM
EHRLICH DONALD JDirectorFeb 10Sale86.008,000688,00069,905Feb 11 05:46 PM
Joyce Thomas Patrick JRPresident and CEOJan 27Option Exercise37.0725,300937,871141,123Jan 28 05:51 PM
Joyce Thomas Patrick JRPresident and CEOJan 27Sale83.9825,3002,124,654115,823Jan 28 05:51 PM
LICO JAMES AExecutive Vice PresidentNov 24Option Exercise37.0755,8402,069,989191,245Nov 25 09:02 AM
LICO JAMES AExecutive Vice PresidentNov 24Sale96.4055,8405,382,808135,405Nov 25 09:02 AM
DANIEL WILLIAM KEVPOct 30Option Exercise37.7539,7401,500,185137,690Nov 02 06:18 PM
DANIEL WILLIAM KEVPOct 30Sale93.0439,7403,697,50997,950Nov 02 06:18 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 23Option Exercise37.0726,400978,64842,492Oct 26 05:53 PM
Joyce Thomas Patrick JRPresident and CEOOct 23Option Exercise37.0725,300937,871141,123Oct 26 05:53 PM
COMAS DANIEL LEVP & CFOOct 23Option Exercise37.0736,2001,341,934135,998Oct 26 05:54 PM
COMAS DANIEL LEVP & CFOOct 23Sale92.7136,2003,356,10299,798Oct 26 05:54 PM
Joyce Thomas Patrick JRPresident and CEOOct 23Sale93.4725,3002,364,892115,823Oct 26 05:53 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 23Sale93.4526,4002,467,02716,092Oct 26 05:53 PM
WY Weyerhaeuser Co. daily Stock Chart
Weyerhaeuser Co.
IndexS&P 500 P/E39.47 EPS (ttm)0.83 Insider Own0.30% Shs Outstand743.85M Perf Week0.89%
Market Cap24.34B Forward P/E27.38 EPS next Y1.20 Insider Trans-22.09% Shs Float738.78M Perf Month11.94%
Income442.00M PEG7.89 EPS next Q0.22 Inst Own79.70% Short Float2.50% Perf Quarter2.89%
Sales7.20B P/S3.38 EPS this Y-36.40% Inst Trans0.00% Short Ratio3.46 Perf Half Y30.53%
Book/sh16.25 P/B2.01 EPS next Y25.13% ROA2.90% Target Price34.39 Perf Year12.19%
Cash/sh0.56 P/C58.65 EPS next 5Y5.00% ROE7.10% 52W Range21.59 - 33.07 Perf YTD11.50%
Dividend1.24 P/FCF- EPS past 5Y-25.80% ROI9.00% 52W High-1.06% Beta1.42
Dividend %3.79% Quick Ratio1.20 Sales past 5Y3.50% Gross Margin19.60% 52W Low51.54% ATR0.59
Employees12600 Current Ratio1.90 Sales Q/Q6.30% Oper. Margin12.60% RSI (14)63.79 Volatility1.48% 1.52%
OptionableYes Debt/Eq0.89 EPS Q/Q-35.40% Profit Margin6.10% Rel Volume0.76 Prev Close32.37
ShortableYes LT Debt/Eq0.89 EarningsAug 05 BMO Payout146.30% Avg Volume5.35M Price32.72
Recom1.80 SMA203.67% SMA507.23% SMA20012.39% Volume4,064,669 Change1.08%
Jun-29-16Upgrade DA Davidson Neutral → Buy
May-09-16Downgrade DA Davidson Buy → Neutral $34 → $33
Feb-17-16Reiterated Argus Buy $43 → $28
Jan-19-16Upgrade Dundee Neutral → Buy
Nov-17-15Reiterated RBC Capital Mkts Outperform $37 → $35
Nov-13-15Upgrade Credit Agricole Underperform → Outperform
Sep-15-15Upgrade BofA/Merrill Neutral → Buy
Jul-16-15Downgrade BofA/Merrill Buy → Neutral
Jun-17-15Initiated Dundee Neutral $34
May-04-15Reiterated UBS Sell $29 → $27
Feb-17-15Reiterated Argus Buy $39 → $43
Nov-03-14Reiterated DA Davidson Buy $37 → $40
Aug-18-14Reiterated Argus Buy $36 → $39
Aug-04-14Upgrade DA Davidson Neutral → Buy $33 → $37
Apr-29-13Reiterated UBS Sell $20 → $24
Jan-29-13Reiterated Argus Buy $33 → $36
Jan-28-13Downgrade RBC Capital Mkts Outperform → Sector Perform $30 → $31
Jan-16-13Reiterated BMO Capital Markets Market Perform $28.50 → $33
Jul-17-12Downgrade BMO Capital Markets Market Perform → Underperform
Jul-06-12Downgrade DA Davidson Buy → Neutral $27 → $23
Jul-28-16 06:03PM  [$$] International Paper Sees Weak Packaging Demand In Brazil Before Olympics at The Wall Street Journal
Jul-27-16 08:10AM  Paper Stocks Reporting Q2 Earnings on Jul 28: IP & MERC
Jul-18-16 03:46PM  The Best REITs Right Now for Returns, Dividends at Investopedia
Jul-15-16 02:01PM  3 Stocks to Buy With Dividends Yielding More Than 4% at Motley Fool
Jul-11-16 09:08AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : July 11, 2016
Jul-10-16 12:00PM  3 Stocks That Pay You to Own Them at Motley Fool
Jul-08-16 10:10AM  Bear of the Day: Weyerhaeuser (WY)
Jul-07-16 08:13AM  Weyerhaeuser (WY) Now a Strong Sell On Gloomy Prospects
Jul-06-16 04:30PM  Weyerhaeuser to release second quarter results on August 5 PR Newswire
Jul-01-16 12:23PM  Third Avenue Management Buys 6 Stocks in Second Quarter
Jun-30-16 07:01AM  Weyerhaeuser to Turn Preference Shares to Common Shares
Jun-29-16 04:20PM  Weyerhaeuser announces conversion of Mandatory Convertible Preference Shares PR Newswire
04:11PM  Weyerhaeuser stock pops, D.A. Davidson calls it 'best in class' at CNBC
09:33AM  Weyerhaeuser (WY) Stock Climbs After D.A. Davidson Upgrade
08:02AM  Weyerhaeuser upgraded by DA Davidson
Jun-28-16 06:04PM  Developer plans 620 apartments on Minneapolis-St. Paul border at
Jun-24-16 05:35PM  Seattle-area stocks: Brexit news punishes Tableau, Juno, Paccar in Friday trading at -6.06%
Jun-23-16 07:47AM  Weyerhaeuser to Close Lumber and Plywood Mill in Montana
Jun-22-16 05:30PM  Weyerhaeuser to close Columbia Falls lumber mill and plywood mill PR Newswire
Jun-20-16 01:19PM  2 Lesser-Known Dividend Stocks to Buy During Times of Extreme Volatility
Jun-18-16 12:01AM  [$$] Canaccord Sees Strategic Fit In Microsoft-LinkedIn Hookup at
Jun-17-16 01:31PM  Weyerhaeuser attracts show of support
01:15PM  International Paper Company -- Moody's assigns Prime-2 short term rating to International Paper Company at Moody's
Jun-16-16 04:23PM  Weyerhaeuser Presses on with Printing Paper Sale After Nippon Deal
07:40AM  Weyerhaeuser to Sell Liquid Packaging Facility to Nippon
06:02AM  WEYERHAEUSER CO Files SEC form 8-K, Other Events
Jun-15-16 11:25PM  Weyerhaeuser sells final piece of cellulose fibers business at
08:00PM  Weyerhaeuser to sell Liquid Packaging Board business to Nippon Paper Industries for $285 million in cash PR Newswire
10:37AM  3 Dividend Growers Rallying Up Summer's Wall Of Worry at Forbes
Jun-08-16 08:06AM  Weyerhaeuser Stock To Trade Ex-Dividend Wednesday (WY) at Investopedia
Jun-03-16 03:50PM  ETFs with exposure to Weyerhaeuser Co. : June 3, 2016
May-31-16 09:55AM  5 Dividend Stocks to Buy in June at Motley Fool
May-25-16 06:01AM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers
May-23-16 12:08PM  Tri Pointe Homes, Inc. -- Moody's Assigns B1 to TRI Pointe's New Senior Notes; Affirms All Ratings; Outlook Positive at Moody's
May-20-16 04:55PM  Weyerhaeuser Company declares dividend on common shares PR Newswire
08:58AM  What Makes Weyerhaeuser Company (WY) A Strong Sell?
May-19-16 08:45AM  New Strong Sell Stocks for May 19th
May-18-16 09:09AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : May 18, 2016
May-17-16 05:07PM  Common And Deadly Investing Mistakes: Buys On The Way Down
05:07PM  Common And Deadly Investing Mistakes: Buys On The Way Down at Investor's Business Daily
May-16-16 01:05AM  Why Ingersoll Rands Net Debt Increased in 1Q16
May-15-16 03:10AM  Third Avenue Management Cuts Real Estate Holdings Heading Into Q2 at Insider Monkey
May-14-16 04:16PM  First Eagle Investment Managements Top Stock Picks This Quarter; Oracle Corp Leads the Pack at Insider Monkey
May-12-16 03:11PM  ETFs with exposure to Weyerhaeuser Co. : May 12, 2016
01:04PM  WEYERHAEUSER CO Financials
May-11-16 10:21AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: Q1, 2016 By the Numbers
May-09-16 04:25PM  Tesla Gets Bullish Report; 2 Recent Medical IPOs Rated As Buys
04:25PM  Tesla Gets Bullish Report; 2 Recent Medical IPOs Rated As Buys at Investor's Business Daily
May-06-16 10:04PM  Edited Transcript of WY earnings conference call or presentation 6-May-16 2:00pm GMT Thomson Reuters StreetEvents
08:16AM  Weyerhaeuser (WY) Beats on Q1 Earnings, Revenues Lag Zacks
07:55AM  Early movers: CI, ICE, SQ, ATVI, YELP, HON, WYNN, GPRO, HLF & more at CNBC
07:07AM  Q1 2016 Weyerhaeuser Co Earnings Release - Before Market Open CCBN
06:02AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
05:03AM  Weyerhaeuser beats 1Q profit forecasts AP
03:05AM  Weyerhaeuser Reports First Quarter Results PR Newswire
May-05-16 06:31PM  Jobs expected to shine even in dull economy at CNBC
04:43PM  Weyerhaeuser (WY) Stock Up in After-Hours Trading Ahead of Q1 Results at TheStreet
May-04-16 04:39PM  WEYERHAEUSER CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obliga EDGAR Online
May-03-16 04:47PM  Weyerhaeuser (WY) Sells Pulp Mills to International Paper Zacks
04:43PM  International Paper to Buy Weyerhaeuser's Pulp Business Zacks
02:06PM  Int'l Paper Not Fretting About Antitrust Review of Weyerhaeuser Deal at The Wall Street Journal
09:30AM  The Zacks Analyst Blog Highlights: Lennar, KB Home, Vulcan Materials, Martin Marietta Materials and Weyerhaeuser Zacks
12:33AM  [$$] Intl Papers Latest Deal Reflects Demand for Diapers, Feminine Products at The Wall Street Journal
May-02-16 02:52PM  [$$] International Paper to Buy Weyerhaeuser's Pulp Ops for $2.2 Billion at The Wall Street Journal
11:34AM  International Paper to buy 7 pulp mills from Weyerhaeuser AP
11:07AM  International Paper makes $1.9 billion acquisition at USA TODAY
10:35AM  Weyerhaeuser sells pulp business to International Paper for $2.2 billion at American City Business Journals
10:22AM  IP Buys Weyerhaeuser Pulp Assets in $2.2B Deal at TheStreet
09:57AM  International Paper to buy Weyerhaeusers fiber pulp business for $2.2 billion at MarketWatch
09:34AM  3 Construction Earnings to Watch this Week: VMC, MLM & WY Zacks
09:23AM  Stocks to Watch: Halliburton, Baker Hughes and Weyerhaeuser at The Wall Street Journal
08:52AM  Stock Futures Rise Following Last Week's Tumble at TheStreet
08:50AM  International Paper to buy Weyerhaeuser's pulp business Reuters
08:33AM  WEYERHAEUSER CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements an EDGAR Online
08:14AM  International Paper to buy Weyerhaeuser's pulp business for $2.2 bln Reuters
08:10AM  International Paper agrees to buy Weyerhaeuser's pulp business in $1.9 billion deal at MarketWatch
08:05AM  Booming Diaper Use Drives $2.2 Billion International Paper Deal at Bloomberg
08:00AM  Weyerhaeuser to sell Cellulose Fibers pulp mills to International Paper for $2.2 billion in cash PR Newswire
07:47AM  Weyerhaeuser (WY) to Report Q1 Earnings: What's in Store? Zacks
Apr-23-16 09:00AM  'Mad Money' Lightning Round: Room to Run for Weyerhaeuser at TheStreet
Apr-17-16 09:14AM  3 High-Yield Dividend Stocks I'd Buy Right Now at Motley Fool
Apr-14-16 04:30PM  Weyerhaeuser commits three million acres in Washington and Oregon to support the reintroduction of the North American Fisher PR Newswire
Apr-11-16 07:00PM  Lightning Round: Best stock of the Dow? at CNBC
Apr-08-16 06:30AM  Weyerhaeuser Names Jim Kilberg Senior Vice President, Real Estate, Energy, and Natural Resources PR Newswire
Apr-05-16 04:30PM  Weyerhaeuser to release first quarter results on May 6 PR Newswire
10:31AM  Lumber Prices Are Gearing Up for a Pullback (CUT, WY) at Investopedia
Apr-04-16 09:12PM  Weyerhaeuser Company -- Moody's says Weyerhaeuser's New Joint Venture Is Credit Positive at Moody's
09:00AM  Silver Creek Capital Management Adds Maine Public Employees Retirement System as Investor to Complete Funding for Twin Creeks Timber Business Wire
01:00AM  HD, SWK, CAT, AAPL: Jim Cramer's Views at TheStreet
Apr-01-16 07:02PM  Cramer: Here is How to Make Money From Today's Jobs Report
08:45AM  Is Weyerhaeuser due for pullback?
Mar-19-16 10:30AM  3 Cheap High-Yield Dividend Stocks You Can Buy Right Now at Motley Fool
Mar-11-16 05:05PM  WEYERHAEUSER CO Files SEC form 8-K/A, Financial Statements and Exhibits
09:00AM  Everett port sells site to California real estate developer at
Mar-10-16 05:04PM  WEYERHAEUSER CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obliga
Mar-06-16 10:20AM  Buy Weyerhaeuser, Get More Than a Great Dividend at TheStreet
Mar-02-16 04:30PM  Weyerhaeuser to present at Citi 2016 Global Property CEO Conference PR Newswire
01:44PM  Value Income Stocks Best Positioned In Current Market
08:54AM  Despite record, commercial real estate shows warning signs
Feb-26-16 06:00AM  'Mad Money' Lightning Round: Not Turning My Back on Weyerhaeuser at TheStreet
Weyerhaeuser Co. is a real estate investment trust. It primarily invests in United States. The firm operates under four business segments, timberlands, wood products, cellulose fibers and real estate. It owns timberlands primarily in the U.S and has long-term licenses in Canada. The firm manufactures wood and specialty cellulose fibers products, and develops real estate, primarily as a builder of single-family homes. Weyerhaeuser Co was founded in 1900 and is based in Federal Way, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hunter Rhonda DSr. Vice PresidentJul 27Option Exercise23.563,31878,16261,768Jul 27 09:06 PM
Hunter Rhonda DSr. Vice PresidentJul 27Sale33.003,318109,49458,450Jul 27 09:06 PM
HOLLEY RICK RDirectorJul 26Option Exercise24.11181,0434,364,595735,113Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 26Sale32.64181,0435,909,092554,070Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Option Exercise24.41426,95710,423,885981,027Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Sale32.51426,95713,881,368554,070Jul 27 06:46 PM
Hunter Rhonda DSr. Vice PresidentJun 30Option Exercise20.423,29267,22361,742Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 30Sale30.003,29298,76058,450Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 20Sale29.126,500189,28058,019Jun 22 03:35 PM
Bozeman David PDirectorJun 09Sale30.301,92958,4566,262Jun 13 12:42 PM
Emmert Mark ADirectorJun 07Sale31.259,536298,0009,715Jun 08 07:56 PM
Merle Denise MSenior Vice PresidentDec 17Sale30.742,58079,31019,990Dec 21 01:57 PM
Bedient Patricia MExecutive Vice President & CFONov 19Option Exercise26.2718,581488,104210,982Nov 20 07:07 PM
Bedient Patricia MExecutive Vice President & CFONov 19Sale32.0018,581594,592192,401Nov 20 07:07 PM
Slater Catherine ISenior Vice PresidentOct 22Option Exercise20.425,483111,93538,480Oct 23 06:38 PM
Hunter Rhonda DSr. Vice PresidentOct 22Option Exercise20.423,29167,18640,502Oct 23 06:48 PM
Hunter Rhonda DSr. Vice PresidentOct 22Sale30.003,29198,73037,211Oct 23 06:48 PM
Slater Catherine ISenior Vice PresidentOct 22Sale30.005,483164,49032,997Oct 23 06:38 PM
Slater Catherine ISenior Vice PresidentOct 19Option Exercise14.803,56752,80240,433Oct 21 05:40 PM
Slater Catherine ISenior Vice PresidentOct 19Sale29.347,436218,17232,997Oct 21 05:40 PM
Hunter Rhonda DSr. Vice PresidentOct 19Sale29.344,567133,99637,211Oct 21 05:13 PM
CAFARO DEBRA ADirectorAug 31Buy27.9717,850499,24522,207Sep 01 02:07 PM
Blocker Adrian MSenior Vice PresidentAug 31Buy27.993,55099,38126,347Sep 01 02:00 PM
CELG Celgene Corporation daily Stock Chart
Celgene Corporation
IndexS&P 500 P/E54.28 EPS (ttm)2.07 Insider Own0.20% Shs Outstand774.10M Perf Week4.34%
Market Cap86.85B Forward P/E15.98 EPS next Y7.02 Insider Trans-5.56% Shs Float772.42M Perf Month13.54%
Income1.68B PEG2.46 EPS next Q1.38 Inst Own80.60% Short Float1.08% Perf Quarter8.49%
Sales9.69B P/S8.97 EPS this Y-18.80% Inst Trans0.22% Short Ratio1.90 Perf Half Y11.83%
Book/sh6.50 P/B17.26 EPS next Y23.30% ROA6.90% Target Price135.82 Perf Year-14.93%
Cash/sh7.37 P/C15.22 EPS next 5Y22.03% ROE29.70% 52W Range92.98 - 136.40 Perf YTD-6.32%
Dividend- P/FCF37.78 EPS past 5Y15.70% ROI8.90% 52W High-17.75% Beta1.23
Dividend %- Quick Ratio4.30 Sales past 5Y20.60% Gross Margin95.60% 52W Low20.66% ATR2.58
Employees6971 Current Ratio4.60 Sales Q/Q20.70% Oper. Margin24.50% RSI (14)69.25 Volatility2.16% 2.21%
OptionableYes Debt/Eq0.00 EPS Q/Q15.00% Profit Margin17.40% Rel Volume1.23 Prev Close111.26
ShortableYes LT Debt/Eq2.81 EarningsJul 28 BMO Payout0.00% Avg Volume4.38M Price112.19
Recom1.90 SMA207.64% SMA508.88% SMA2005.03% Volume5,397,739 Change0.84%
Jul-15-16Initiated Stifel Buy $138
Apr-29-16Reiterated Sun Trust Rbsn Humphrey Buy $145 → $147
Feb-25-16Initiated Citigroup Buy $130
Jan-20-16Initiated Credit Suisse Outperform
Jan-14-16Initiated Standpoint Research Buy $130
Jan-08-16Initiated Sun Trust Rbsn Humphrey Buy $145
Jan-07-16Initiated Sun Trust Rbsn Humphrey Buy
Nov-06-15Reiterated UBS Buy $156 → $145
Oct-01-15Upgrade JP Morgan Neutral → Overweight
Sep-09-15Initiated Jefferies Buy
Sep-01-15Initiated Raymond James Strong Buy $160
Jul-24-15Reiterated UBS Buy $142 → $156
Jul-24-15Reiterated JMP Securities Mkt Outperform $133 → $147
Jul-24-15Reiterated Cantor Fitzgerald Buy $146 → $163
Jul-21-15Reiterated Piper Jaffray Overweight $144 → $160
Jul-15-15Reiterated RBC Capital Mkts Outperform $135 → $150
Jul-15-15Reiterated Barclays Equal Weight $120 → $130
Feb-25-15Reiterated Argus Buy $130 → $155
Dec-09-14Reiterated UBS Buy $112 → $130
Dec-09-14Reiterated Argus Buy $102 → $130
Jul-29-16 05:25PM  Final trades: Tesoro, Celgene and more
11:58AM  Biotech Stocks: The End of Political Risk? at
10:10AM  Company News for July 29, 2016
09:00AM  Celgene Corporation Nails the Second Quarter at Motley Fool
Jul-28-16 03:04PM  Celgene Is Heading Even Higher -- Here's How to Trade It Now
02:37PM  This Small Gain Is a Big Win for Celgene Corporation at Motley Fool
02:30PM  [$$] Celgene Lifts Guidance as Revlimid Sales Rise at The Wall Street Journal
01:58PM  Celgene Set to Squeeze Short Sellers (CELG, IBB) at Investopedia
01:49PM  U.S. biotech stocks win back investors in big July run
01:25PM  3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday
12:33PM  Celgene Beats Estimates, Raises Earnings Outlook at TheStreet
12:28PM  Jim Cramer Says Oncology Drug Franchises Helping Both Celgene and Bristol-Myers at TheStreet
12:11PM  Celgene (CELG) Tops Q2 Earnings & Revenues, Lifts View
11:14AM  Celgene: Doing What Amgen and Gilead Couldn't at
10:21AM  3 Stocks That Could Double Your Money at Motley Fool
10:03AM  Short-Sellers Shy Away From These 2 Biotechs This Settlement Period
09:17AM  Celgene (CELG) Beats on Q2 Earnings and Revenues
09:09AM  U.S. biotech Celgene raises forecast as profit beats Street
09:05AM  How Celgene Won With This Earnings Report at 24/7 Wall St.
08:36AM  Celgene Reports Second-Quarter Results, Highlights 'Outstanding' 2016 Performance
08:16AM  Pharma earnings roundup
08:02AM  Celgene Second-Quarter Earnings Yield No Surprises, Small Guidance Bump
07:58AM  Celgene beats Street 2Q forecasts
07:55AM  Celgene (CELG) Stock Climbs on Q2 Earnings, Revenue Beat
07:40AM  Celgene revenue rises on higher demand for flagship drug Revlimid
07:36AM  CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:36AM  Celgene Raises Guidance as Sales of Top Drug Revlimid Grow at Bloomberg
07:30AM  Celgene Reports Second Quarter 2016 Operating and Financial Results Business Wire
07:07AM  Q2 2016 Celgene Corp Earnings Release - Before Market Open
Jul-27-16 03:25PM  Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure
09:47AM  Watch for Drug Stocks Earnings on Jul 28: BMY, CELG & More
08:20AM  JPMorgan Bullish on Biotech: 3 Top Picks to Buy Now at 24/7 Wall St.
07:50AM  Major Biotechs See Increased Short Interest Bets at 24/7 Wall St.
Jul-26-16 04:39PM  Celgene Slides After Deciding Against Revlimid Label Expansion
03:00PM  Why EverBank, Celgene, Centene, PACCAR, and Wolverine World Wide Are Trending Today at Insider Monkey
02:20PM  3 Things to Watch as Celgene Corporation Reports Earnings at Motley Fool
10:34AM  Why Gilead Can't Easily Copy Celgene's 'Partner Partner Partner' Deal-Making Playbook
10:30AM  Celgene: So Much For That Buying Opportunity at
08:30AM  Morning Movers: BUD, VZ, CELG, GS
08:21AM  An Investing Overview of the Multiple Sclerosis Market at Motley Fool
06:05AM  CELGENE CORP /DE/ Files SEC form 8-K, Other Events
Jul-25-16 06:08PM  Celgene Falls After Blockbuster Cancer Drug Revlimid Fails To Extend Survival
05:30PM  Celgene drug fails to extend survival in lymphoma study Reuters
05:06PM  Celgene Can't Expand Revlimid Approval Into Non-Hodgkin Lymphoma Just Yet
04:59PM  What Are Analysts Recommendations for Biogen in 2016?
04:57PM  Celgene shares slide after Revlimid use expansion curbed at MarketWatch
04:30PM  Celgene and LYSARC Provide Update on the Phase III REMARC Study of REVLIMID® Maintenance Treatment in Patients with Diffuse Large B-Cell Lymphoma Responding to First-Line R-CHOP Therapy Business Wire
01:05PM  3 Top Biotech Stocks to Buy Now at Motley Fool
11:44AM  Gilead Sciences: What Do Analysts Recommend?
11:28AM  Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise?
11:15AM  Gilead Sciences Kicks Off 5 Big Pharma Earnings This Week
11:05AM  Understanding Improvement in Vertex Pharmaceuticalss PE Multiple
09:05AM  How Kanuma Addition to Alexions Portfolio Impacts Its Earnings
08:53AM  The Market In 5 Minutes: Yahoo, Outerwall Highlight Merger Monday
05:00AM  This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles
Jul-23-16 07:01AM  I Just Bought These 4 Fast-Growing Biotech Stocks at Motley Fool
Jul-22-16 12:00PM  Celgene (CELG) Stock Is the Chart of the Day
Jul-21-16 03:54PM  Will Alexion Pharmaceuticals 2Q16 Earnings Surprise?
10:02AM  Biogen: CEO Departing; Is This Drug Maker In Play? at
09:30AM  The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul-20-16 03:36PM  Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
12:20PM  Cambridges Jounce announces hefty $2.5B deal with Celgene for cancer drugs at
09:47AM  Biotech: As Cheap as They Come at
09:43AM  Celgene (CELG), Jounce Strike Immunotherapy Collaboration
08:02AM  3 Perfect Stocks for People in Their 40s to Consider Buying at Motley Fool
Jul-19-16 07:21AM  Celgene and Jounce Therapeutics will collaborate on next-gen cancer treatments at MarketWatch
07:21AM  3 Biotech Stocks to Buy and Hold at Motley Fool
07:01AM  Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact
07:00AM  [$$] Celgene to partner Jounce in battle against cancerous cells at Financial Times
07:00AM  Celgene to collaborate with tiny Jounce on cancer immunotherapy
07:00AM  [$$] Third Rock Launches Rare-Disease Drug Maker Fulcrum Therapeutics With $55M at The Wall Street Journal
07:00AM  Jounce Therapeutics Announces Major Strategic Collaboration with Celgene Corporation to Develop Next-generation Immuno-oncology Therapies for Patients with Cancer GlobeNewswire
07:00AM  A startup that wants to take cancer therapy to the next level just landed a $2.5 billion deal
Jul-18-16 06:45PM  Celgene's Revlimid Gains EU Nod for Mantle Cell Lymphoma
12:07PM  Biogen: Key Analyst Recommendations in 2016
08:16AM  Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : July 18, 2016
Jul-15-16 04:07PM  Apple Price Target Cut; Nvidia, Chipotle, Delta Downgraded
08:53AM  5 Toxic Stocks to Sell as Anxiety Creeps Higher
08:19AM  Does Biogen's Lower P/E Ratio Make It a Better Buy Than Celgene? at Motley Fool
07:25AM  Coverage initiated on Celgene by Stifel
02:00AM  REVLIMID® (Lenalidomide) Approved by the European Commission for the Treatment of Relapsed/Refractory Patients with Mantle Cell Lymphoma Business Wire
Jul-14-16 04:22PM  3 Big Pharma Stocks That Could Raise Their Dividends at Motley Fool
03:55PM  Better Days Ahead for Biotech at
10:42AM  How Much Do Stock Prices Matter in Biotech? at Motley Fool
07:55AM  Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons
Jul-13-16 03:43PM  Why Investors Are Underestimating Gilead Sciences at Motley Fool
11:29AM  [$$] Three Biotech Picks With Pipeline Upside at
08:10AM  Short Sellers Become More Selective on Major Biotechs at 24/7 Wall St.
Jul-12-16 01:38PM  [$$] Funding Snapshot: Sapience Therapeutics Raises $22.5M Series A at The Wall Street Journal
12:21PM  Which Pipeline Has Better Potential: Celgene or Biogen? at Motley Fool
10:10AM  Biotechs With Drug Pipelines Closest to Zero Valuation at 24/7 Wall St.
09:08AM  Whats Driving Regenerons Premium Valuation?
Jul-11-16 10:05AM  The Word on the Street: How Analysts See BioMarin Now
10:05AM  Why Did BioMarins Share Price Tank after Brexit?
05:11AM  Four high-quality biotech companies trading like risky startups at MarketWatch
Jul-08-16 03:33PM  Celgene Shares Likely to Jump on Potential $2B 'Orphan' Drug: RBS
03:33PM  Celgene Shares Likely to Jump on Potential $2B 'Orphan' Drug: RBC
01:02PM  Celgene: Why Juno's Flop Doesn't Matter at
01:13AM  [$$] Juno Shares Plunge as Drug Trial Placed on Hold After Patient Deaths at The Wall Street Journal
Jul-07-16 06:33PM  [$$] Juno Shares Plunge as Drug Trial Placed on Hold After Patient Deaths at The Wall Street Journal
Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID to treat multiple myeloma; and OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, ankylosing spondylitis, Behcet's disease, atopic dermatitis, and ulcerative colitis. The company's products also include VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); THALOMID for the patients with multiple myeloma and erythema nodosum leprosum; ISTODAX to treat cutaneous and peripheral T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN products. Its clinical stage products include OTEZLA for the treatment of various immune-inflammatory diseases; sotatercept for the treatment of renal anemia, beta-thalassemia and MDS; luspatercept for beta-thalassemia and MDS; CC-486 to treat MDS, AML, and solid tumors; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; PDA-002 for the treat diabetic foot ulcers and peripheral neuropathy; and PNK-007 for hematological malignancies treatment. The company has collaborative agreements with Novartis Pharma AG; Acceleron Pharma; Agios Pharmaceuticals, Inc.; Epizyme Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; Acetylon Pharmaceuticals, Inc.; OncoMed Pharmaceuticals, Inc.; NantBioScience, Inc.; AstraZeneca PLC; Lycera Corp.; Juno Therapeutics, Inc.; TriNetX, Inc.; Triphase Accelerator Corporation; and Nurix, Inc. The company was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARIO ERNESTDirectorJul 01Option Exercise0.007330105,058Jul 05 04:32 PM
LOUGHLIN JAMES JDirectorJul 01Option Exercise0.00733022,919Jul 05 04:30 PM
Friedman Michael ADirectorJul 01Option Exercise0.0073300Jul 05 04:27 PM
KAPLAN GILLADirectorJul 01Option Exercise0.00733081,852Jul 05 04:28 PM
COX CARRIE SMITHDirectorJul 01Option Exercise0.00733023,146Jul 05 04:27 PM
BARKER RICHARD WDirectorJul 01Option Exercise0.00733011,551Jul 05 04:25 PM
CASEY MICHAEL DDirectorJul 01Option Exercise0.0073300Jul 05 04:26 PM
HUGIN ROBERT Jsee remarksJun 20Sale100.1675,0007,512,0001,122,201Jun 22 04:42 PM
KAPLAN GILLADirectorJun 17Option Exercise0.00333081,119Jun 17 04:18 PM
Friedman Michael ADirectorJun 17Option Exercise0.0033300Jun 17 04:14 PM
CASEY MICHAEL DDirectorJun 17Option Exercise0.0033300Jun 17 04:13 PM
COX CARRIE SMITHDirectorJun 16Option Exercise0.006,200022,413Jun 17 04:14 PM
MARIO ERNESTDirectorJun 16Option Exercise0.002,0550113,892Jun 16 06:57 PM
KAPLAN GILLADirectorJun 15Option Exercise0.006,200080,786Jun 17 04:18 PM
LOUGHLIN JAMES JDirectorJun 12Option Exercise0.002,068021,853Jun 13 05:10 PM
MARIO ERNESTDirectorJun 12Option Exercise0.002,0680103,992Jun 13 05:10 PM
KAPLAN GILLADirectorJun 12Option Exercise0.002,068074,586Jun 13 05:09 PM
BARKER RICHARD WDirectorJun 12Option Exercise0.002,068011,439Jun 13 05:08 PM
CASEY MICHAEL DDirectorJun 12Option Exercise0.002,06800Jun 13 05:08 PM
Friedman Michael ADirectorJun 12Option Exercise0.002,06800Jun 13 05:09 PM
Alles Mark JSee RemarksApr 29Option Exercise0.0011,0000164,636May 03 04:30 PM
HUGIN ROBERT Jsee remarksApr 29Option Exercise0.0060,00001,228,311May 03 04:19 PM
Smith Scott AndrewSee RemarksApr 29Option Exercise0.0010,000036,656May 03 09:28 PM
MARIO ERNESTDirectorApr 26Option Exercise31.805,000158,975101,924Apr 28 04:09 PM
KAPLAN GILLADirectorApr 04Sale101.8415,9671,626,07972,518Apr 05 04:15 PM
BONNEY MICHAEL WDirectorMar 03Buy103.012,000206,0282,000Mar 04 04:33 PM
LOUGHLIN JAMES JDirectorFeb 22Sale104.122,100218,65219,785Feb 24 04:56 PM
MARIO ERNESTDirectorFeb 01Option Exercise29.0018,600539,400101,049Feb 02 04:50 PM
Alles Mark JSee RemarksJan 29Option Exercise27.5121,938603,586139,685Feb 02 04:46 PM
HUGIN ROBERT Jsee remarksJan 15Option Exercise26.4522,680599,8411,168,311Jan 20 09:24 AM
CASEY MICHAEL DDirectorDec 23Sale122.1120,0002,442,200125,485Dec 28 04:03 PM
KAPLAN GILLADirectorDec 21Option Exercise16.2114,464234,461102,949Dec 22 04:12 PM
CASEY MICHAEL DDirectorDec 21Option Exercise110.8460,0006,650,400145,485Dec 22 04:11 PM
KAPLAN GILLADirectorDec 21Sale110.6214,4641,600,00888,485Dec 22 04:12 PM
Smith Scott AndrewSee RemarksDec 17Option Exercise0.005,000029,248Dec 18 04:22 PM
KARSEN PERRY Asee remarksDec 17Option Exercise0.007,500070,320Dec 18 04:21 PM
FOUSE JACQUALYN Asee remarksDec 17Option Exercise0.007,500061,611Dec 18 04:20 PM
Alles Mark JSee RemarksDec 17Option Exercise0.0011,6700123,117Dec 18 04:19 PM
Smith Scott AndrewSee RemarksDec 03Option Exercise0.0010,000029,433Dec 07 04:16 PM
CASEY MICHAEL DDirectorSep 08Option Exercise14.2515,000213,75015,000Sep 10 08:23 AM
CASEY MICHAEL DDirectorSep 08Sale121.7615,0001,826,4000Sep 10 08:23 AM
Daniel Thomas Osee remarksAug 10Option Exercise34.6125,578885,27587,756Aug 12 04:38 PM
Daniel Thomas Osee remarksAug 10Sale130.8225,5783,346,11462,178Aug 12 04:38 PM
MARIO ERNESTDirectorJul 31Sale131.7319,4422,561,139122,449Aug 04 04:01 PM
CVS CVS Health Corporation daily Stock Chart
CVS Health Corporation
IndexS&P 500 P/E20.12 EPS (ttm)4.61 Insider Own0.20% Shs Outstand1.08B Perf Week-3.97%
Market Cap100.00B Forward P/E14.13 EPS next Y6.56 Insider Trans-6.78% Shs Float1.07B Perf Month-1.36%
Income5.15B PEG1.35 EPS next Q1.30 Inst Own85.70% Short Float1.15% Perf Quarter-7.33%
Sales160.17B P/S0.62 EPS this Y16.80% Inst Trans0.58% Short Ratio2.39 Perf Half Y-3.19%
Book/sh32.99 P/B2.81 EPS next Y12.65% ROA5.90% Target Price112.26 Perf Year-16.55%
Cash/sh1.73 P/C53.65 EPS next 5Y14.93% ROE14.00% 52W Range80.05 - 111.80 Perf YTD-3.92%
Dividend1.70 P/FCF21.52 EPS past 5Y13.30% ROI9.40% 52W High-17.07% Beta0.83
Dividend %1.83% Quick Ratio0.60 Sales past 5Y9.90% Gross Margin16.90% 52W Low15.83% ATR1.22
Employees155000 Current Ratio1.20 Sales Q/Q18.90% Oper. Margin5.90% RSI (14)35.44 Volatility1.64% 1.21%
OptionableYes Debt/Eq0.76 EPS Q/Q-3.50% Profit Margin3.20% Rel Volume1.19 Prev Close93.39
ShortableYes LT Debt/Eq0.73 EarningsAug 02 BMO Payout31.70% Avg Volume5.15M Price92.72
Recom1.80 SMA20-3.05% SMA50-3.16% SMA200-4.55% Volume6,115,493 Change-0.72%
Jun-23-16Reiterated Mizuho Buy $117 → $108
Jun-22-16Reiterated Deutsche Bank Hold $105 → $99
Jun-20-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-04-16Reiterated RBC Capital Mkts Outperform $110 → $115
May-04-16Reiterated Mizuho Buy $104 → $117
Mar-10-16Reiterated Barclays Overweight $110 → $115
Feb-10-16Reiterated Mizuho Buy $113 → $104
Feb-03-16Initiated Atlantic Equities Overweight
Jan-22-16Initiated Robert W. Baird Outperform $108
Dec-18-15Resumed Barclays Overweight $110
Dec-17-15Reiterated Oppenheimer Outperform $115 → $117
Dec-17-15Downgrade Goldman Buy → Neutral
Aug-28-15Reiterated Oppenheimer Outperform $122 → $119
Aug-10-15Reiterated Argus Buy $114 → $118
Aug-05-15Reiterated RBC Capital Mkts Outperform $117 → $132
Jul-22-15Reiterated Deutsche Bank Hold $108 → $117
Jun-18-15Initiated Oppenheimer Outperform $119
Jun-09-15Initiated Macquarie Outperform $115
May-22-15Reiterated Jefferies Buy $120 → $125
Feb-13-15Reiterated Deutsche Bank Hold $100 → $109
Jul-29-16 01:34PM  CVS Health To Boost Access To FDA-approved Nasal Naloxone For Patients Without Insurance
10:11AM  CVS Health to Increase Access to FDA-approved Nasal Naloxone for Patients without Insurance through Improved Affordability of NARCAN® Nasal Spray at CVS Pharmacy Locations PR Newswire
08:06AM  Is CVS Health Getting Healthy?
Jul-28-16 08:21AM  CVS Health Corp: Earnings Preview at Motley Fool
Jul-27-16 06:43PM  CVS Health (CVS) Q2 Earnings: What's in the Cards?
Jul-26-16 09:47AM  How one investor is playing CVS Caremark
08:25AM  CVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : July 26, 2016
Jul-25-16 11:10AM  CVS Health Says Overdose-Reversal Drug Is Now Available Without A Prescription In Texas
08:39AM  CVS Health to make opioid overdose-reversal drug available without prescription in Texas at MarketWatch
08:30AM  CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Texas PR Newswire
Jul-23-16 01:06PM  3 Stocks That Retirees Should Consider Buying Today at Motley Fool
12:04PM  3 Healthcare Stocks to Hold Forever at Motley Fool
12:01AM  This Weekend's Barron's: Day of Reckoning for Pharmacy-Benefit Companies? ~ Special Monthly Report on Alternative Investments ~ Six Stocks that Could Surprise on Earnings at
12:01AM  [$$] Pharmacy-Benefit Managers Under Pressure at
Jul-22-16 12:00PM  CVS Health Corporation To Hold Second Quarter 2016 Conference Call PR Newswire
Jul-21-16 07:04PM  Jerome Dodson Goes 3 for 3 in Second Quarter
Jul-20-16 04:44PM  UnitedHealth's Obamacare Shun, Recent Deals, Make It Attractive for the Future
04:08PM  Recent Dip in CVS Shares Presents Buying Opportunity, Analysts Say
10:22AM  Better Buy: CVS Health Corp vs. Express Scripts at Motley Fool
Jul-18-16 11:28AM  Avoid Telecom And Utility Stocks, Buy These Instead at Forbes
Jul-15-16 08:59AM  Why The Walgreens-Rite Aid Deal May Be Closer To Getting OK
08:30AM  CVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : July 15, 2016
07:22AM  3 Stocks to Buy and Hold Forever at Motley Fool
Jul-14-16 09:44AM  An Aging Population Makes These 3 Stocks Screaming Buys at Motley Fool
Jul-13-16 09:04AM  A Quick Look at Walgreenss Valuations
Jul-12-16 08:07PM  Walgreenss Stock Tumbles despite FIscal 3Q16 Earnings Beat
08:05PM  How Did Allergans Anda Distribution Segment Perform?
03:05PM  VEREIT CEO Says Turnaround Plan Is Succeeding
09:08AM  What Was Behind Walgreens Boots Alliances Earnings Beat in 3Q16?
Jul-11-16 06:33PM  CVS Health (CVS) Works to Cut Down on Readmission Rates
02:44PM  Bull case for large-caps
09:07AM  How Was Walgreenss Retail Pharmacy Business Performance in the US?
Jul-09-16 10:39AM  These 4 Stocks Can Save You From The Next Market Crash at Forbes
12:01AM  [$$] Quest for Income Cuts Dividend Yield on Many S&P Groups at
Jul-08-16 04:43PM  What pharmacies are doing in wake of N.C.'s new opioid/heroin law at
01:40PM  CVS and Walgreens: A Duopoly That's Hard to Ignore
Jul-07-16 01:28PM  5 Stocks Being Unfairly Punished (NFLX,SFM,KR) at Investopedia
09:00AM  CVS Health Foundation and American Academy of Pediatrics Announce New Initiative to Reduce Exposure to Secondhand Smoke PR Newswire
08:30AM  CVS Health Research Institute Study Shows that Medication Reconciliation Programs Can Reduce Hospital Readmissions PR Newswire
08:00AM  MinuteClinic Announces New Travel Health Services Just in Time for Summer Vacation Season PR Newswire
Jul-06-16 11:57PM  CVS Health Declares Quarterly Dividend at Investopedia
03:01PM  CVS Health Dividend Offers 1.8% Yield
01:46PM  Baltimore man pleads guilty to cutting fire hose during 2015 riot
01:05PM  CVS Health Corporation Announces Quarterly Dividend PR Newswire
12:23PM  Walgreens Expects to Shutter Only 500 Stores After Rite-Aid Deal Closes at Fortune
11:40AM  Trump Or Hillary? Either Way, There's A Way To Profit at Forbes
08:30AM  CVS Pharmacy Opens Mobile Pharmacy in Elkview, West Virginia Following Severe Flooding PR Newswire
Jul-05-16 06:14PM  What To Watch In Walgreens Q3 Results at Forbes
07:46AM  Nurse Practitioners Launch Ad Blitz To Lift VA Hurdle at Forbes
Jul-04-16 09:21AM  3 Top Healthcare Stocks to Buy Now at Motley Fool
Jul-02-16 10:43AM  3 Healthcare Stocks That Could Raise their Dividends at Motley Fool
Jul-01-16 02:11PM  CVS Offers a Superb Bet on the Drug and Health Care Spending Boom
11:03AM  How the DEA could introduce big pharma to marijuana at MarketWatch
Jun-30-16 03:08PM  Walgreens: Wall Streets Views and Valuations
03:08PM  Walgreens: Wall Streets Views and Valuations at Market Realist
Jun-29-16 04:29PM  A Look at Walgreens ahead of Its Fiscal 3Q16 Results
03:33PM  Congressman Luján, NM Sec. of Health Gallagher, Santa Fe County Sheriff Garcia Join CVS Health To Highlight Availability of Overdose-Reversing Medication At CVS Pharmacy Locations Across New Mexico PR Newswire
10:03AM  3 Retirement Stocks to Buy in July at Motley Fool
Jun-28-16 07:48AM  Domtar Acquires Butterfly Health to Boost Personal Care
Jun-27-16 03:43PM  When Will Gilead Sciences, Celgene, and CVS Health Hit $100 Again? at Motley Fool
Jun-24-16 03:18PM  Express Scripts shares languish as Anthem dispute weighs
Jun-23-16 05:06PM  Moody's Affirms Four and Upgrades One Class of GMAC 1999-C2 at Moody's
08:00AM  MinuteClinic Expands With New Walk-in Medical Clinics Inside South Florida Target Stores PR Newswire
Jun-22-16 01:00PM  IBM Watson Imaging Collaborative Adds 16 Health Systems, Tech Firms at Forbes
12:00PM  CVS Pharmacy Now Open in Target Stores Throughout Colorado PR Newswire
10:07AM  CVS Health (CVS) Stock Rises, Deutsche Bank Drops Target Price
Jun-21-16 04:22PM  CVS: First No Cigarettes; Now More Paleo And Vegan Foods
02:40PM  Stocks Move Higher as 'Brexit' Vote Looms
09:00AM  MinuteClinic Expands With New Walk-in Medical Clinics Inside Dallas-Fort Worth Target Stores PR Newswire
08:53AM  Stock Futures Rise as Markets Prepare for Yellen Testimony
08:15AM  CVS will expand its healthier foods initiative to more than 2,900 stores at MarketWatch
08:04AM  CVS Pharmacy Expands Healthy Foods Initiative PR Newswire
06:00AM  This health care player youve never heard of is acting aggressively to keep costs down at MarketWatch
06:00AM  Heres Why Youll Likely Pay More for Your Employer-Sponsored Health Insurance at Fortune
Jun-20-16 04:13PM  CVSs stock drops after Morgan Stanley gives up on its bullish view at MarketWatch
01:30PM  Trending Tickers: MRO, WMT, CVS, NKE
11:19AM  Stocks Maintain Highs as 'Brexit' Relief Fuels Global Rally
08:41AM  Stock Futures Point to Big Gains as 'Brexit' Polls Suggest Shift Toward 'Remain'
07:07AM  CVS Health downgraded by Morgan Stanley
Jun-17-16 07:25PM  Seattle-based Bartell Drugs has some new competition: CVS at
11:54AM  Universal Orlando parent, Wells Fargo, CVS Health chip in $1.4M to mass shooting victims relief fund at
Jun-16-16 03:41PM  This Retailer Is Amazon-Proof at Motley Fool
12:05PM  CVS Health Isn't Looking So Healthy
11:00AM  CVS Health CEO Larry Merlo Keynotes at 2016 AHIP Institute and Expo PR Newswire
Jun-15-16 05:45PM  Hawaiis 6 Target stores complete conversions to Longs Drugs pharmacies at
Jun-14-16 05:38PM  Stocks Manning & Napier Continues Buying
04:46PM  CVS HEALTH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:15PM  CVS Health Corporation Announces Final Results of Tender Offers PR Newswire
03:25PM  CVS moving St. Louis operations to Phoenix; 77 to be laid off at
03:07PM  1 Stock to Invest in Healthcare at Motley Fool
10:16AM  Instant Analysis: Walgreens Boots Alliance Terminates Theranos Partnership at Motley Fool
Jun-13-16 10:30AM  United Health: With General Electric Win, is PBM Rethinking in Order? at
08:30AM  This Leader Is 18% Undervalued... And That's Just the Beginning
Jun-12-16 02:00PM  3 Mutual Funds That Rely on Strong M&A (EMAYX, GAKIX) at Investopedia
01:46PM  Three Must Read Stories: The Weekend Reader at The Wall Street Journal
06:00AM  5 Things You May Not Know About CVS (But Should) at Fortune
Jun-09-16 09:56AM  These Cheap Stocks Could Be Perfect for Investors in Their 50s at Motley Fool
08:28AM  Stefano Pessina Could Be Setting Up A Succession Plan At Walgreens at Forbes
Jun-08-16 03:09PM  [$$] Target's Valuation and 3.5% Yield Make It a Buy at
01:00PM  CVS Pharmacy Now Open in Target Stores Throughout Oregon PR Newswire
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MERLO LARRY JPresident and CEOMay 05Option Exercise36.2338,2471,385,689280,381May 06 04:26 PM
GOLD STEPHEN JEVP & CIOMay 05Option Exercise47.299,798463,34731,358May 06 04:29 PM
GOLD STEPHEN JEVP & CIOMay 05Sale105.009,7981,028,79021,560May 06 04:29 PM
Brennan Troyen AEVP and Chief Medical OfficerMay 05Sale105.007,517789,28569,601May 06 04:28 PM
MERLO LARRY JPresident and CEOMay 05Sale105.0038,2474,015,935242,134May 06 04:26 PM
GOLD STEPHEN JEVP & CIOApr 01Option Exercise47.2921,9221,036,69142,048Apr 05 06:39 PM
Sussman AndrewEVP & Pres, CVS MinuteClinicApr 01Sale105.002,844298,62011,041Apr 05 07:21 PM
GOLD STEPHEN JEVP & CIOApr 01Sale105.0021,9222,301,81020,126Apr 05 06:39 PM
Brennan Troyen AEVP, Chief Medical OfficerMar 09Sale100.006,755675,50069,601Mar 11 04:08 PM
Roberts Jonathan CEVP & President, CVS/caremarkFeb 11Sale92.8623,3552,168,74528,644Feb 11 05:17 PM
MERLO LARRY JPresident and CEOFeb 01Option Exercise28.1046,3931,303,643208,021Feb 02 04:17 PM
MERLO LARRY JPresident and CEOFeb 01Sale96.1446,3934,460,010161,628Feb 02 04:17 PM
MERLO LARRY JPresident and CEOJan 11Option Exercise28.1046,3931,303,643208,006Jan 13 04:16 PM
MERLO LARRY JPresident and CEOJan 11Sale95.0046,3934,407,335161,613Jan 13 04:16 PM
Finucane Anne A.DirectorJan 04Sale95.872,000191,74914,719Jan 05 05:10 PM
Brennan Troyen AEVP, Chief Medical OfficerOct 27Option Exercise54.5323,6031,287,07285,444Oct 28 04:50 PM
Brennan Troyen AEVP, Chief Medical OfficerOct 27Sale105.0023,6032,478,31561,841Oct 28 04:50 PM
XLV Health Care Select Sector SPDR ETF daily Stock Chart
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.28%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month5.86%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter8.19%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.60 Perf Half Y14.00%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year0.29%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range55.76 - 76.09 Perf YTD5.20%
Dividend1.13 P/FCF- EPS past 5Y- ROI- 52W High-1.16% Beta-
Dividend %1.50% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low34.86% ATR0.76
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)68.66 Volatility0.79% 0.89%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.51 Prev Close75.05
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume9.51M Price75.20
Recom- SMA201.82% SMA504.53% SMA2008.27% Volume4,803,200 Change0.20%
Jul-29-16 11:36AM  Buy Merck on Near-Term Weakness
07:40AM  Why some see unloved health-care stocks as a screaming buy at MarketWatch
07:15AM  Beyond Merck's yield is value: Pro
Jul-28-16 09:07AM  What Drove Edwards Lifesciences THVT Revenues in 2Q16?
09:07AM  Mercks 2Q16 Estimates: Expected Growth Contributors
Jul-27-16 11:06AM  Biogen Misses EndPoints in Synergy Trial for Opicinumab
11:04AM  What Is Johnson & Johnsons Valuation?
09:12AM  What to Expect from Becton, Dickinson and Company in Fiscal 3Q16
09:10AM  Is Zimmer Biomet Expected to Post Revenue Growth for 2Q16?
08:16AM  Edwards Lifesciences 2Q16 Earnings Surpass Analyst Estimates
Jul-26-16 11:18AM  Analysts Take on Zimmer Biomet Holdings before 2Q16 Earnings
09:44AM  Buy Express Scripts at $73, Not Near $77
09:08AM  Whats Boosted Investors Confidence in Biogen in 2016?
Jul-25-16 01:32PM  Thermo Fisher Scientifics 2Q16 Revenues: Whats in Store?
09:49AM  Sector Flows: Should Equity Bulls Be Worried?
09:30AM  The Zacks Analyst Blog Highlights: Health Care Select Sector SPDR Fund, iShares U.S. Consumer Services ETF, First Trust Utilities AlphaDEX Fund and PowerShares S&P SmallCap Utilities Portfolio ETF
09:05AM  Orkambi Launch Impacts Vertex Pharmaceuticalss Major Revenue Contributor
Jul-22-16 02:04PM  GILD Developing Next Generation HCV Drugs to Remain Competitive
01:28PM  St. Jude Medical Gets Hold Rating from 96% of Analysts
01:16PM  Is Vertex Pharmaceuticals Exposed to Drug Pricing Risks?
01:16PM  How Alexion Plans to Fuel Strensiq Sales
01:14PM  Why Johnson & Johnsons 2Q16 Profits Fell by 11.5%
01:07PM  What Are Lillys 2Q16 Estimates and Expectations for Elanco?
07:29AM  Abbotts 2Q16 Earnings Propelled by Impressive Sales Growth
05:42AM  Summer's top summer sector: Health care
Jul-21-16 02:00PM  3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings
08:16AM  4 Healthcare Mutual Funds to Buy on Bright Prospects
Jul-20-16 12:04PM  Behind the bull market
10:13AM  Richard Bernstein on Profits Recession and Portfolio Positioning
Jul-19-16 06:20PM  Dow ETF Notches Fresh Closing High As Blue Chip Stocks Take The Reins
02:24PM  Inside Bill Ackmans Current Stance and View of His Holdings
08:58AM  How to Profit From Abbott Labs
Jul-15-16 01:19PM  For this rally to continue, there must be a change in leadership at MarketWatch
10:29AM  Analysts Ratings of St. Jude Medical before 2Q16 Results
04:23AM  Analysts Latest Recommendations for Intuitive Surgical
Jul-14-16 08:41PM  Abbott Laboratories: Analyst Recommendations before 2Q16 Results
11:56AM  Could the Dow Jump Up Another 400 Points by Year-End?
10:04AM  What Do Analysts Recommend for UNH ahead of 2Q16 Earnings?
Jul-13-16 09:07AM  Will June Jobs Report Speed Up the Feds Next Rate Hike?
Jul-12-16 09:06PM  Regenerons Robust Pipeline
08:06PM  How Are Thermo Fishers Commercial Capabilities Driving Its Share Gains?
06:06PM  What Are Varians Key Initiatives for the Particle Therapy Business?
Jul-11-16 11:42AM  GICS Sectors: Investors Err on the Side of Caution
07:03AM  Does the Rebound in Non-Farm Payrolls Favor a Rate Hike?
01:05AM  A Look at Alexions 2016 Guidance
Jul-09-16 07:05AM  Are Stocks Ready To Rocket Higher?
Jul-08-16 04:35PM  Medtronics Heartware Acquisition: Portfolio Impact
Jul-07-16 05:26PM  Humana stock tumbles nearly 10% steepest daily drop in 4 years at MarketWatch
Jul-06-16 11:50AM  The Driverless City
09:23AM  Health Care Stocks Are Quietly Moving Higher
Jul-05-16 03:06PM  Will General Electrics Healthcare Segment Score in 2Q16?
02:00PM  A Look at the Health Care Select Sector SPDR Fund (XLV, JNJ) at Investopedia
07:05AM  The Amsurg-Envision Material Adverse Effect Clause: Part 3
Jul-01-16 01:33PM  Brexit is a result of slow growth forever at MarketWatch
Jun-30-16 10:41AM  Brexit Bounce Still Favors Bearish Outcome (XLF, XLB) at Investopedia
Jun-29-16 04:21PM  Fund Managers Flocked To Energy, Materials in 2Q at
02:06PM  Why Did Alexion Fall after Brexit?
01:56PM  The Amsurg-Envision Material Adverse Effect Clause: Part 2
01:55PM  The Amsurg-Envision Material Adverse Effect Clause: Part 1
07:12AM  Shire's stock surges after ADHD drug trial meets key endpoints at MarketWatch
Jun-28-16 02:55PM  What New Medicines Were Recommended during the CHMPs June Meeting?
01:06PM  Bill Ackman Is Dead Wrong for Shorting Herbalife, Says Carl Icahn
11:16AM  Private Insurance Doesn't Mean Lower Out-Of-Pocket Costs
11:07AM  Inside AbbVies Analyst Recommendations in 2016
Jun-27-16 06:08PM  Carl Icahn Says Allergan Is Undervalued, Takes a Large Position
02:05PM  Which Sector of the S&P 500 Index Could Gain in a Flat Market?
Jun-26-16 07:21AM  The 5 Best Healthcare ETFs at Motley Fool
Jun-24-16 04:39PM  Brexit may make health care stocks a good defensive play at MarketWatch
10:38AM  How Healthcare ETFs Could Really Get it Together
09:05AM  Whats the Main Regulatory Risk of the Envision-Amsurg Deal?
Jun-23-16 09:07AM  Could the Envision-Amsurg Deal Get Competitive?
08:23AM  Studies Show Regular Exercise Cannot Counteract Harm Of Sitting All Day At Work
Jun-22-16 11:38AM  Pharma stocks are soaring for the first time in weeks because something didn't happen
09:06AM  What Are the Conditions for the Amsurg-Envision Merger?
Jun-21-16 09:07AM  Whats the Rationale for the Amsurg-Envision Merger?
06:00AM  Health care spending to shift in 2017: PwC
Jun-15-16 11:30AM  Analyzing XLV: It Managed to Stay above $70
Jun-14-16 12:36PM  Monday links: all the risks
Jun-13-16 12:24PM  Centene to Raise $500 Million through Senior Notes
Jun-10-16 03:15PM  Bond yields tumble as traders run to safety
07:30AM  Industrials Flirting with All-Time Highs
Jun-09-16 11:24AM  Valeant Pharmaceuticals: Equity Investors Heartened By Debt Rating Decision at
09:07AM  What Caused Alexion Pharmaceuticals Fall?
Jun-08-16 02:59PM  Why Biogens Stock Price Has Fallen
Jun-07-16 06:08PM  Health ETFs Wilt But Broad U.S. Stock Market Continues To Rally
02:03PM  Biotech Smacked Despite Broad U.S. Stock Rally at
Jun-06-16 03:34PM  Humana Rose on Aetnas $13 Billion Bond Sale
Jun-05-16 01:46PM  The Utilities Sector Gets A Lot More Volatile In The Summer
Jun-02-16 02:18PM  This Chart May Hold Key To Stock Rallys Fate
11:09AM  XLVs Holdings: How Are the Moving Averages Trending?
10:51AM  11 Health Care ETFs for a Heart-Healthy Portfolio
Jun-01-16 01:25PM  Vertex Receives FDA Nod for Priority Review of Orkambi
01:25PM  XLV Broke the $70 Jinx: Its Working to Reach a 3-Month High
10:08AM  How to Invest in US Large-Cap Equity Mutual Funds Going Forward
10:00AM  A Healthy Assessment of Healthcare ETFs
09:07AM  The Healthcare & Biotechnology Index Surprised Markets in April
08:57AM  Your first trade for Wednesday, June 1 at CNBC
May-31-16 04:44PM  Do US GICS Sector Flows Suggest Caution Right Now?
May-27-16 04:16PM  Whats Allergans Growth Strategy?
04:16PM  How Do Allergans Valuations Compare to Its Peers?
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
CAG ConAgra Foods, Inc. daily Stock Chart
ConAgra Foods, Inc.
IndexS&P 500 P/E42.51 EPS (ttm)1.10 Insider Own0.20% Shs Outstand437.70M Perf Week-0.65%
Market Cap20.47B Forward P/E17.79 EPS next Y2.63 Insider Trans-30.12% Shs Float436.94M Perf Month-1.24%
Income479.60M PEG5.84 EPS next Q0.48 Inst Own77.60% Short Float1.05% Perf Quarter5.50%
Sales11.64B P/S1.76 EPS this Y-36.90% Inst Trans0.02% Short Ratio1.70 Perf Half Y13.54%
Book/sh8.48 P/B5.51 EPS next Y9.27% ROA-4.70% Target Price51.00 Perf Year7.73%
Cash/sh1.91 P/C24.53 EPS next 5Y7.28% ROE-19.30% 52W Range37.32 - 48.55 Perf YTD12.85%
Dividend1.00 P/FCF61.15 EPS past 5Y-10.30% ROI10.50% 52W High-3.68% Beta0.35
Dividend %2.14% Quick Ratio0.80 Sales past 5Y-1.20% Gross Margin27.10% 52W Low25.30% ATR0.63
Employees20900 Current Ratio1.40 Sales Q/Q-9.50% Oper. Margin8.30% RSI (14)48.36 Volatility1.40% 1.30%
OptionableYes Debt/Eq1.49 EPS Q/Q-112.10% Profit Margin-5.90% Rel Volume0.88 Prev Close46.41
ShortableYes LT Debt/Eq1.32 EarningsJun 30 BMO Payout- Avg Volume2.70M Price46.76
Recom2.40 SMA20-1.24% SMA500.45% SMA2009.07% Volume2,372,827 Change0.75%
Jul-01-16Reiterated RBC Capital Mkts Sector Perform $48 → $50
Apr-08-16Reiterated Jefferies Buy $50 → $52
Apr-04-16Reiterated RBC Capital Mkts Sector Perform $46 → $48
Feb-25-16Resumed Goldman Neutral $48
Feb-12-16Upgrade BofA/Merrill Neutral → Buy
Dec-16-15Initiated Jefferies Buy
Sep-25-15Reiterated Deutsche Bank Hold $38 → $43
Jul-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $37 → $50
Jul-01-15Upgrade BofA/Merrill Underperform → Neutral
Jun-22-15Upgrade JP Morgan Neutral → Overweight
Jun-19-15Reiterated Deutsche Bank Hold $36 → $38
Jun-19-15Reiterated Bernstein Mkt Perform $37 → $44
Sep-19-14Reiterated RBC Capital Mkts Sector Perform $31 → $35
Feb-12-14Reiterated Deutsche Bank Hold $35 → $31
Nov-26-13Initiated RBC Capital Mkts Sector Perform $33
Sep-11-13Reiterated Barclays Overweight $40 → $38
Apr-03-13Reiterated Deutsche Bank Hold $35 → $40
Feb-20-13Reiterated Deutsche Bank Hold $31 → $32
Jan-24-13Reiterated UBS Buy $38 → $36
Nov-28-12Reiterated Deutsche Bank Hold $29 → $31
Jul-29-16 01:17PM  Jefferies Increases ConAgra Foods Price Target to $56 per Share
09:07AM  Whats Expected of Kraft Heinzs Revenue in 2Q16?
Jul-28-16 03:19PM  71% of Analysts Recommend Buys on KHC before Its 2Q16 Results
12:45PM  California's tomato business is just plain rotten and farmers are seeing red at CNBC
Jul-27-16 03:24PM  ConAgra Foods (CAG) Stock Price Target Raised at Jefferies
11:09AM  ConAgra Foods Completed the Sale of Its Two Businesses
08:23AM  ConAgra Foods, Inc. breached its 50 day moving average in a Bearish Manner : CAG-US : July 27, 2016
Jul-25-16 04:33PM  Platinum Equity Completes Acquisition of JM Swank Marketwired
04:27PM  ConAgra Foods Completes Sales of JM Swank and Spicetec Flavors & Seasonings Business Wire
12:52PM  ETFs with exposure to ConAgra Foods, Inc. : July 25, 2016
Jul-22-16 01:06PM  Key Moving Averages: Comparing Bunge and Its Peers
10:54AM  ConAgra Foods, Inc. :CAG-US: Earnings Analysis: Q4, 2016 By the Numbers : July 22, 2016
09:03AM  ConAgra Foods, Inc. :CAG-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016
Jul-21-16 03:32PM  Why Kellogg Company Fell 5% on July 20
01:04PM  CONAGRA FOODS INC /DE/ Financials
12:55PM  ConAgra closing another St. Louis plant, laying off 69 at
Jul-20-16 01:48PM  ConAgra Extends P.F. Chang's Home Menu Products' Recall On Possible Metal Fragments Presence
12:51PM  Roving candy, cookie towers: How supermarkets sway shoppers
Jul-19-16 05:16PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Finan
12:07PM  Will Ingredion Continue Positive Earnings Growth in 2Q16?
Jul-18-16 01:06PM  ConAgra Foods Appoints David Marberger as CFO
10:09AM  P.F. Chang's Frozen Meals Recalled Over Metal Shards
08:30AM  This Company Could Be In The Economic Sweet Spot
Jul-16-16 03:08PM  ConAgra Foods Expands Recall of P.F. Changs Home Menu Brand Meals Due to Potential Presence of Foreign Material Business Wire
Jul-15-16 07:13PM  Wolverine World Wide Declared Dividend of $0.06 per Share
07:10PM  Who Were the Outliers in the Consumer Space on July 14?
02:14PM  CONAGRA FOODS INC /DE/ Files SEC form 10-K, Annual Report
07:47AM  CFO Moves: ConAgra, Prestige Brands, Brink's at The Wall Street Journal
Jul-14-16 06:00PM  [$$] ConAgra Foods Names Marberger as Next CFO at The Wall Street Journal
05:08PM  ConAgra hires CFO from Prestige Brands
04:30PM  ConAgra Foods Names David Marberger Chief Financial Officer Business Wire
03:35PM  ConAgra Moves Forward With Spinoff Plans at Investopedia
12:20AM  [$$] Business Briefs at The Wall Street Journal
Jul-13-16 07:57PM  [$$] Business Watch at The Wall Street Journal
05:05PM  ConAgra Foods Declares Dividend of $0.25 per Share
11:42AM  ConAgra Foods (CAG) Stock Up, Names CEO of Lamb Weston Spinoff
10:36AM  Why Traders Are Talking About Allergan, Teva, and 3 Other Stocks Today at Insider Monkey
08:25AM  ConAgra files to split into two companies at
08:14AM  [$$] ConAgra Names CEO, Chairman of Potato Business Spinoff at The Wall Street Journal
07:47AM  ConAgra Foods Proceeds With Spinoff of Lamb Weston Division at Bloomberg
07:40AM  ConAgra Foods Files Form 10 For Planned Spinoff
06:57AM  ConAgra files for split into two companies, names executives of new Lamb Weston at MarketWatch
06:35AM  ConAgra Foods Files Form 10 Registration Statement for Planned Spin-off, Announces Key Lamb Weston Leadership Positions Business Wire
Jul-12-16 02:01PM  ConAgra Foods Dividend Offers 2.10% Yield
12:00PM  Weekly CFO Sells Highlights
09:58AM  ConAgra (CAG) Adds Organic Items to Healthy Choice Menu
07:00AM  ConAgra Foods Announces Dividend Payment Business Wire
Jul-11-16 08:36AM  Healthy Choice to introduce meals with organic ingredients at MarketWatch
08:01AM  New Organic Ingredient Meals From Healthy Choice Make Eating Organic Even Easier PR Newswire
Jul-07-16 01:54PM  P.F. Changs Entrees Are Being Recalled for Probable Metal Pieces at Fortune
Jul-06-16 11:06AM  Did Analysts Recommendations Change for SJM after Fiscal 4Q16?
10:15AM  ConAgra Growth Initiatives Impress, Stiff competition a Drag
Jul-05-16 08:04AM  Analysts' Actions -- CyberArk, Nordstrom, Netflix, Skyworks and More
Jul-04-16 09:07AM  How Did ConAgra Foods Perform in Fiscal 4Q16?
Jul-02-16 12:01AM  [$$] TreeHouse Reaches New Heights With Ralcorp Merger at
Jul-01-16 02:33PM  ConAgra Still Appetizing Despite Quant Downgrade
11:49AM  ConAgra - time for a defensive move
06:24AM  No Deal: Hershey Rejects Mondelezs Takeover Offer
Jun-30-16 04:15PM  Earnings Wrap: Constellation, ConAgra, Paychex, McCormick, Darden
02:32PM  ConAgra (CAG) Posts In-Line Q4 Earnings, Splits Business
12:06PM  Why ConAgra Foods, Hertz Global, Shire PLC and Two Other Stocks Are on the Move Today at Insider Monkey
11:43AM  Earnings Wrap: Constellation, ConAgra, Paychex, McCormick, Darden at Investor's Business Daily
11:27AM  ConAgra (CAG) Stock Down on Mixed Q4 Results at TheStreet
11:27AM  ConAgra (CAG) Stock Down on Mixed Q4 Results
10:47AM  What Made J.M. Smuckers Stock Rally 15% in June?
10:47AM  What Made J.M. Smuckers Stock Rally 15% in June? at Market Realist
10:35AM  ConAgra Slips On In-Line Q4 Earnings, Light Revenue at
10:03AM  ConAgra Shares Slump as Higher Prices on Frozen Meals Hurt Sales at Bloomberg
09:30AM  ConAgra Foods Inc Earnings Call scheduled for 9:30 am ET today
09:10AM  ConAgra (CAG) Q4 Earnings in Line, Revenues Miss
08:42AM  ConAgra Foods Q4 Sales Miss, Plans To Separate
07:57AM  ConAgra Foods shares slide after revenue miss at MarketWatch
07:52AM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
07:42AM  ConAgra meets 4Q profit forecasts AP
07:30AM  CAG: Continued Margin Progress Drives Q4 EPS as Planned; Fiscal 2016 Portfolio, Margin, Balance Sheet Progress Sets Strong Foundation Business Wire
07:07AM  Q4 2016 ConAgra Foods Inc Earnings Release - 07:30 am ET CCBN
Jun-29-16 11:34PM  U.S. Stocks Turn Positive for the Year at The Wall Street Journal
05:27PM  Investing Action Plan For Thursday: Stress-Test Relief For Bank Stocks, Constellation Brands
05:15PM  The Numbers Don't Lie: Is ConAgra Lining Up for Deals?
05:15PM  The Numbers Don't Lie: Is ConAgra Lining Up for Deals? at Bloomberg
10:12AM  ConAgra May Leave Investors Hungry For Info After Earnings at
09:30AM  Zacks Investment Ideas feature highlights: J.M. Smucker, ConAgra, Post Holdings and United Natural Foods
08:40AM  Treehouse Foods Hits 52-Week High on Strong Q1 Results
06:58AM  Jefferies Raises McCormicks Target Price to $100 per Share
Jun-28-16 05:08PM  Food Stocks to Buy into a Brexit Panic
04:08PM  Top Stock Picks for the Week of June 27th
03:03PM  ConAgra vs McCormick: Which Will Win the Earnings Showdown?
02:36PM  ConAgra Foods (CAG) Stock Lower Ahead of Q4 Results
10:53AM  ConAgra's Lamb Weston/Meijer Business to Form JV in Russia
09:06AM  What Are Wall Street Analysts Recommendations for ConAgra?
Jun-27-16 10:05PM  Analyzing ConAgra Foods Performance in Fiscal 3Q16
12:05PM  What Could Cast a Shadow on ConAgras EPS in Fiscal 4Q16?
11:54AM  Morgan Stanley Says Buy These 14 Stocks for a Post-Brexit Bargain
11:03AM  ConAgra Foods' European Partner Announces Agreement to Serve Russian Market Through Joint Venture Business Wire
09:49AM  Will Q3 Earnings Hold a Surprise for ConAgra (CAG) Stock?
09:07AM  Can ConAgra Foods Revive its Revenue Growth in 4Q16?
Jun-26-16 08:30PM  Limiting your Brexit exposure
02:00PM  Brexit Fallout, Nike Earnings, and Wimbledon5 Things to Know for the Week Ahead at Fortune
Jun-24-16 09:32AM  Will ConAgra Foods Stock Gain from Its Fiscal 4Q16 Results?
09:31AM  Will Divestiture Help ConAgra Foods Drive Its Growth?
ConAgra Foods, Inc., together with its subsidiaries, operates as a food company in North America. The company operates through two segments: Consumer Foods and Commercial Foods. The Consumer Foods segment principally sells branded food in various categories, including meals, entrees, condiments, pasta, sides, snacks, and desserts in various retail channels across frozen, refrigerated, and shelf-stable temperature. It offers its products under the ACT II, Banquet, Blue Bonnet, Chef Boyardee, DAVID, Egg Beaters, Healthy Choice, Hebrew National, Hunt's, Marie Callender's, Orville Redenbacher's, PAM, Peter Pan, Reddi-wip, Slim Jim, Snack Pack, Swiss Miss, Van Camp's, and Wesson brands. The Commercial Foods segment sells branded and private label food and ingredients, primarily to commercial, foodservice, restaurant, food manufacturing, and industrial customers. It provides food items, such as frozen potato and sweet potato items; and various vegetable, spice, and frozen bakery goods under the Lamb Weston and Spicetec Flavors & Seasonings brands. ConAgra Foods, Inc. was founded in 1919 and is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wise Robert GSVP, Corporate ControllerJul 15Option Exercise36.8915,708579,46834,326Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 15Sale47.9015,708752,36618,618Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 14Option Exercise30.8917,245532,69835,863Jul 18 04:21 PM
Wise Robert GSVP, Corporate ControllerJul 14Sale48.1917,245830,97418,618Jul 18 04:21 PM
JURGENSEN WILLIAM GDirectorJul 08Option Exercise24.549,000220,860119,356Jul 08 04:51 PM
JURGENSEN WILLIAM GDirectorJul 08Sale47.884,636221,972114,720Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Option Exercise24.549,000220,86089,850Jul 08 04:50 PM
GOLDSTONE STEVEN FDirectorJul 07Option Exercise24.5481,1681,991,863191,922Jul 08 04:51 PM
GOLDSTONE STEVEN FDirectorJul 07Sale48.0441,4701,992,132150,452Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Sale48.104,607221,59785,243Jul 08 04:50 PM
Johri RajiveDirectorJul 06Option Exercise21.4715,000322,05051,259Jul 08 04:56 PM
Johri RajiveDirectorJul 06Sale47.5315,000712,87736,259Jul 08 04:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Option Exercise36.8936,6541,352,16655,272Jul 07 08:47 PM
Gehring JohnEVP and CFOJul 05Option Exercise34.58159,0575,499,729218,766Jul 07 08:56 PM
Gehring JohnEVP and CFOJul 05Sale48.14159,0577,657,06859,709Jul 07 08:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Sale48.1636,6541,765,27118,618Jul 07 08:47 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Option Exercise30.8912,992401,323118,541Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Sale46.3512,992602,179105,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Option Exercise24.7410,000247,400115,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Sale46.2510,000462,500105,549Apr 13 04:51 PM
McGough Thomas MPresident, Consumer FoodsApr 07Option Exercise26.1560,0001,569,000116,341Apr 11 04:50 PM
McGough Thomas MPresident, Consumer FoodsApr 07Sale46.0060,0002,760,00056,341Apr 11 04:50 PM
Gehring JohnEVP and CFOJan 06Option Exercise25.45320,0008,142,400379,709Jan 08 04:26 PM
Wise Robert GSVP, Corporate ControllerJan 06Option Exercise30.8922,992710,22341,610Jan 08 04:30 PM
Wise Robert GSVP, Corporate ControllerJan 06Sale41.9722,992965,00918,618Jan 08 04:30 PM
Gehring JohnEVP and CFOJan 06Sale41.67320,00013,335,32859,709Jan 08 04:26 PM
Johri RajiveDirectorDec 24Option Exercise16.806,750113,40038,319Dec 29 05:55 PM
Johri RajiveDirectorDec 24Sale42.216,750284,89731,918Dec 29 05:55 PM
GILD Gilead Sciences Inc. daily Stock Chart
Gilead Sciences Inc.
IndexS&P 500 P/E6.80 EPS (ttm)11.69 Insider Own0.50% Shs Outstand1.34B Perf Week-8.18%
Market Cap106.68B Forward P/E6.47 EPS next Y12.29 Insider Trans-16.07% Shs Float1.32B Perf Month-3.40%
Income17.34B PEG8.66 EPS next Q3.02 Inst Own81.90% Short Float1.68% Perf Quarter-9.40%
Sales32.84B P/S3.25 EPS this Y62.00% Inst Trans-0.20% Short Ratio2.18 Perf Half Y-3.25%
Book/sh9.69 P/B8.20 EPS next Y2.29% ROA36.60% Target Price110.37 Perf Year-31.33%
Cash/sh6.20 P/C12.82 EPS next 5Y0.79% ROE105.70% 52W Range77.92 - 118.14 Perf YTD-20.64%
Dividend1.88 P/FCF6.70 EPS past 5Y48.30% ROI45.90% 52W High-32.74% Beta1.11
Dividend %2.37% Quick Ratio1.60 Sales past 5Y32.60% Gross Margin86.90% 52W Low1.99% ATR2.13
Employees8000 Current Ratio1.80 Sales Q/Q2.60% Oper. Margin65.40% RSI (14)35.94 Volatility2.43% 2.02%
OptionableYes Debt/Eq1.70 EPS Q/Q-8.60% Profit Margin52.80% Rel Volume1.90 Prev Close81.24
ShortableYes LT Debt/Eq1.57 EarningsJul 25 AMC Payout14.30% Avg Volume10.21M Price79.47
Recom2.10 SMA20-6.85% SMA50-5.89% SMA200-14.14% Volume19,450,913 Change-2.18%
Jul-29-16Downgrade Argus Buy → Hold
Jul-26-16Reiterated RBC Capital Mkts Outperform $120 → $105
Jul-26-16Downgrade Needham Buy → Hold
Jun-01-16Initiated Gabelli & Co Buy $109
Apr-29-16Reiterated UBS Buy $130 → $118
Apr-29-16Downgrade Maxim Group Buy → Hold
Mar-16-16Reiterated Leerink Partners Outperform $130 → $127
Feb-25-16Initiated Citigroup Buy $110
Feb-12-16Reiterated Maxim Group Buy $137 → $115
Feb-03-16Reiterated RBC Capital Mkts Outperform $130 → $120
Feb-03-16Reiterated Piper Jaffray Overweight $134 → $114
Feb-03-16Reiterated Oppenheimer Outperform $124 → $120
Feb-03-16Reiterated Barclays Overweight $130 → $115
Feb-03-16Initiated Standpoint Research Buy $110
Jan-20-16Initiated Credit Suisse Outperform $125
Jan-15-16Upgrade BofA/Merrill Underperform → Neutral $107
Oct-28-15Reiterated Maxim Group Buy $129 → $137
Oct-20-15Reiterated Oppenheimer Outperform $120 → $124
Oct-02-15Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-09-15Initiated Jefferies Hold
Jul-29-16 04:57PM  Merck posts strong 2Q numbers, while building for long term
04:17PM  Amazon, Alphabet Price Targets Hiked; Ford, Gilead Downgraded
02:56PM  Gilead (GILD) Stock Down on Q3 Outlook, Argus Downgrades
01:57PM  Growth Products Drove Amgens Revenue Performance in 2Q16
11:58AM  Biotech Stocks: The End of Political Risk? at
11:05AM  Why Key Analyst Sees More Headwinds for Gilead Sciences at 24/7 Wall St.
11:04AM  Genvoya Becomes Most Prescribed Regimen for HIV Patients in US
10:56AM  Gilead Sciences: A Hard Wind is Gonna Blow at
09:43AM  What Awaits ACUR & Other Drug Stocks this Earnings Season?
09:04AM  How Gilead Sciences New HIV Drugs Performed in 2Q16
08:55AM  Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dow Chemical, Ford, Gilead, Harley-Davidson, Western Digital and More at 24/7 Wall St.
08:45AM  Morning Movers: Exxon Sinks on Earnings Miss; AbbVie Gains at
07:13AM  Gilead Sciences downgraded by Argus
Jul-28-16 05:03PM  10 Most Undervalued Companies for the Enterprising Investor - July
02:23PM  Research Reports for Facebook, DuPont, Gilead & Others
01:49PM  U.S. biotech stocks win back investors in big July run
01:25PM  3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday
11:14AM  Celgene: Doing What Amgen and Gilead Couldn't at
11:06AM  Gilead Sciences Sees Weak Sales for Its HCV Drug Internationally
09:30AM  The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene
09:08AM  Gilead Sciences Seeks Growth from New HCV Patients
08:18AM  5 Blue-Chip Breakouts to Buy This Summer
Jul-27-16 05:08PM  Gilead Sciences Is Still a Buy
03:33PM  Gilead's Valuation Makes It a Screaming Buy
03:25PM  Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure
12:31PM  Medicaid Restrictions Are Affecting Gileads Hepatitis C Drug Sales
12:31PM  Gileads Profit Margin Squeezed by Drop in Hepatitis C Drug Sales
11:51AM  Medivation: When Earnings are an Afterthought at
11:50AM  What to Look for in Amgen Earnings at 24/7 Wall St.
10:21AM  The Drug-Price War Just Took a Big New Twist at Motley Fool
10:18AM  Yes, Biotech Stocks are Still Ridiculously Cheap (But Only if You Exclude Gilead) at
08:23AM  Gilead Sciences, Inc. breached its 50 day moving average in a Bearish Manner : GILD-US : July 27, 2016
07:50AM  Major Biotechs See Increased Short Interest Bets at 24/7 Wall St.
Jul-26-16 07:01PM  Cramer: For Texas Instruments and Gilead, It's all About Trajectory -8.47%
05:30PM  Stocks finish mixed; Gilead and McDonald's fall as Texas Instruments jumps at Los Angeles Times
04:55PM  After GILD Earnings, Which Biomed Stock is Best Right Now?
04:42PM  Gilead Downgraded As Hepatitis C Declines Faster Than Expected
03:34PM  Harvoni Sales Declines Hurt Gilead Sciences Inc. in Q2 at Motley Fool
03:13PM  Gilead Sciences: Enough is Enough at
02:42PM  Stocks Trade Mixed as Crude Settles Under $43
02:16PM  Gilead plummets on weak outlook and downgrades at Silicon Beat
01:40PM  Gilead Sciences (GILD) Stock Plunges on Q2 Results, RBC Cuts Price Target
01:32PM  Stocks Lower As Selling Picks Up Late In Day; Restaurants Tumble
12:51PM  Jerome Dodson Comments on Gilead
12:33PM  Gilead Science's Falls Most in Almost Three Months
12:33PM  Gilead Science's Falls Most in Almost Three Months at Bloomberg
12:21PM  3 Key Takeaways Following Gilead Sciences' Second-Quarter Conference Call at Motley Fool
11:50AM  Why Analysts Are Thinking M&A Is Back on the Table for Gilead at 24/7 Wall St.
11:09AM  Bristol-Myers Squibbs 2Q16 Estimates: Virology Segment
11:07AM  Gliding's Not Enough for Gilead at Bloomberg
10:34AM  Why Gilead Can't Easily Copy Celgene's 'Partner Partner Partner' Deal-Making Playbook
10:07AM  Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View
09:56AM  Stocks slightly higher as investors monitor company earnings
09:43AM  Earnings Reports Have Investors Abuzz About Gilead, Las Vegas Sands, 3 Other Stocks at Insider Monkey
09:39AM  Gilead Sciences: M&A Now? Please? at
09:30AM  The Zacks Analyst Blog Highlights: Texas Instruments, Gilead Sciences and Las Vegas Sands
09:06AM  Gilead Sciences Continues to Explore Opportunities
08:50AM  Top Analyst Upgrades and Downgrades: Gilead, Sprint, Starbucks, Southwest Air, Texas Instruments, Disney, Nordstrom and More at 24/7 Wall St.
08:24AM  Stock Futures Mixed as Fed Meets, Verizon and McDonald's Tumble
08:17AM  Stocks to Watch: July 26, 2016
06:43AM  Wait On The DNC Before Going Long Biotech ETFs
06:17AM  Wait for Another 10% Drop In Gilead Before Buying
02:07AM  Edited Transcript of GILD earnings conference call or presentation 25-Jul-16 8:30pm GMT
01:04AM  [$$] More Patience Needed at Gilead at The Wall Street Journal
Jul-25-16 09:01PM  7 Key Figures From Gilead Sciences' Q2 Earnings at Motley Fool
08:30PM  Gilead Stock Falls 4% After Guidance Miss (GILD) at Investopedia
07:16PM  [$$] Gilead Sales of Hepatitis C Drugs Fall 19% at The Wall Street Journal
06:13PM  After-hours buzz: TXN, GILD, LVS & more at CNBC
06:02PM  [$$] More Patience Needed at Gilead at The Wall Street Journal
05:53PM  After The Close: Gilead, Las Vegas Sands, Texas Instruments Earnings
05:49PM  Q2 Earnings After the Bell Monday: TXN, GILD, LVS
05:39PM  Gilead (GILD) Stock Falls on Sales Miss and Lower 2016 Revenues Guidance
05:28PM  Gilead Trims Guidance But Beats Q2 Earnings Estimates
05:02PM  GILEAD SCIENCES INC Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements and Exh
04:37PM  Why Analysts Were Not Satisfied With Gilead Earnings at 24/7 Wall St.
04:30PM  Gilead Sciences Inc Earnings Call scheduled for 4:30 pm ET today
04:26PM  Gilead shares drop as drug maker cuts product sales outlook at MarketWatch
04:20PM  Gilead Lowers Product Sales Guidance on Weak Hepatitis C Sales
04:17PM  Gilead tops 2Q profit forecasts
04:15PM  GILEAD SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
04:10PM  Gilead Sciences Announces Third Quarter 2016 Dividend Business Wire
04:08PM  Gilead Sciences Announces Second Quarter 2016 Financial Results Business Wire
04:03PM  These 5 Healthcare Stocks Are Ridiculously Cheap at Motley Fool
12:06PM  Yee: Biotech stocks will outperform after election
12:00PM  Bracing for a 'bio-wreck'?
11:44AM  Gilead Sciences: What Do Analysts Recommend?
11:44AM  How Does Gilead Sciences Valuation Compare to Peers?
11:41AM  Limited gains seen for Gilead Sciences
11:15AM  Gilead Sciences Kicks Off 5 Big Pharma Earnings This Week
10:57AM  Gilead Sciences: Expect an Earnings Beat? at
09:05AM  What to Expect From Gilead Sciences Earnings at 24/7 Wall St.
08:53AM  The Market In 5 Minutes: Yahoo, Outerwall Highlight Merger Monday
08:30AM  Will Gilead Earnings Rebound this Quarter?
07:07AM  Q2 2016 Gilead Sciences Inc Earnings Release - After Market Close
05:12AM  AP Exclusive: Pricey drugs overwhelm Medicare safeguard
05:00AM  This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles
Jul-24-16 03:38PM  Scott Bauer's Gilead Sciences Trade
02:06PM  5 Reasons Biotech Stocks Are Smart Investments at Motley Fool
10:12AM  10 Must-See Earnings for the Coming Week at 24/7 Wall St.
07:41AM  3 Stocks That Turned $10,000 Into $1 Million at Motley Fool
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company's products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, as well as diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MILLIGAN JOHN FPresident and CEOJul 05Option Exercise16.40112,0001,836,2401,170,963Jul 07 02:50 PM
MILLIGAN JOHN FPresident and CEOJul 05Sale84.33112,0009,444,9211,058,963Jul 07 02:50 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Option Exercise24.912,00049,81063,122Jul 06 01:26 PM
MARTIN JOHN CExecutive ChairmanJul 01Option Exercise16.40100,0001,639,5004,119,727Jul 06 01:28 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Sale83.122,000166,25061,122Jul 06 01:26 PM
MARTIN JOHN CExecutive ChairmanJul 01Sale84.73100,0008,472,5234,019,727Jul 06 01:28 PM
MILLIGAN JOHN FPresident and CEOJun 06Option Exercise16.40112,0001,836,2401,170,963Jun 08 06:59 PM
MILLIGAN JOHN FPresident and CEOJun 06Sale86.94112,0009,736,7791,058,963Jun 08 06:59 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Option Exercise24.912,00049,81063,122Jun 03 04:46 PM
MARTIN JOHN CExecutive ChairmanJun 01Option Exercise16.40100,0001,639,5004,119,727Jun 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Sale87.022,000174,04061,122Jun 03 04:46 PM
MARTIN JOHN CExecutive ChairmanJun 01Sale86.72100,0008,671,9504,019,727Jun 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Option Exercise33.8857,0921,934,021118,214Jun 02 04:35 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Sale86.8557,0924,958,60061,122Jun 02 04:35 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Option Exercise39.132,00078,25563,122May 04 04:23 PM
MARTIN JOHN CExecutive ChairmanMay 02Option Exercise16.40100,0001,639,5004,119,727May 04 02:44 PM
MILLIGAN JOHN FPresident and CEOMay 02Option Exercise16.40112,0001,836,2401,170,963May 04 02:49 PM
MARTIN JOHN CExecutive ChairmanMay 02Sale87.82100,0008,781,6944,019,727May 04 02:44 PM
MILLIGAN JOHN FPresident and CEOMay 02Sale87.71112,0009,823,9541,058,963May 04 02:49 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Sale88.722,000177,44861,122May 04 04:23 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Option Exercise26.9935,874968,239177,964Apr 21 01:28 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Sale100.0140,0004,000,574137,964Apr 21 01:28 PM
MILLIGAN JOHN FPresident and CEOApr 04Option Exercise16.40112,0001,836,2401,170,963Apr 05 07:30 PM
MILLIGAN JOHN FPresident and CEOApr 04Sale94.59112,00010,593,9041,058,963Apr 05 07:30 PM
MARTIN JOHN CExecutive ChairmanApr 01Option Exercise16.40100,0001,639,5004,119,727Apr 05 07:49 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Option Exercise24.912,00049,81063,122Apr 05 06:36 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Sale91.342,000182,68061,122Apr 05 06:36 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Sale91.235,000456,158142,090Apr 05 07:45 PM
MARTIN JOHN CExecutive ChairmanApr 01Sale93.24100,0009,323,5074,019,727Apr 05 07:49 PM
Alton Gregg HEVP, Corp & Med AffairsMar 14Sale90.005,000450,000147,090Mar 15 07:31 PM
MARTIN JOHN CChairman and CEOMar 01Option Exercise16.40100,0001,639,5004,119,727Mar 03 02:47 PM
MILLIGAN JOHN FPresident, COO and DirectorMar 01Option Exercise16.40112,0001,836,2401,170,963Mar 03 02:54 PM
Carter Paul RutherfordEVP Commercial OpsMar 01Option Exercise24.912,00049,81063,122Mar 03 03:10 PM
Carter Paul RutherfordEVP Commercial OpsMar 01Sale87.902,000175,80061,122Mar 03 03:10 PM
MILLIGAN JOHN FPresident, COO and DirectorMar 01Sale87.79112,0009,832,9951,058,963Mar 03 02:54 PM
MARTIN JOHN CChairman and CEOMar 01Sale88.58100,0008,857,8544,019,727Mar 03 02:47 PM
Washington Robin LEVP, CFOFeb 16Sale90.726,250567,00084,688Feb 18 07:59 PM
MARTIN JOHN CChairman and CEOFeb 01Option Exercise16.40100,0001,639,5004,048,066Feb 03 05:43 PM
Carter Paul RutherfordEVP Commercial OpsFeb 01Option Exercise39.142,00078,27150,783Feb 03 05:42 PM
MARTIN JOHN CChairman and CEOFeb 01Sale83.42100,0008,342,4753,948,066Feb 03 05:43 PM
Carter Paul RutherfordEVP Commercial OpsFeb 01Sale82.322,000164,64048,783Feb 03 05:42 PM
Carter Paul RutherfordEVP Commercial OpsJan 04Option Exercise25.762,00051,52650,783Jan 06 05:08 PM
MARTIN JOHN CChairman and CEOJan 04Option Exercise16.40100,0001,639,5004,048,066Jan 06 05:21 PM
MARTIN JOHN CChairman and CEOJan 04Sale97.68100,0009,767,7083,948,066Jan 06 05:21 PM
Carter Paul RutherfordEVP Commercial OpsJan 04Sale99.202,000198,40048,783Jan 06 05:08 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSODec 15Option Exercise21.9970,0001,539,562197,936Dec 17 03:40 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSODec 15Sale102.4170,0007,168,741127,936Dec 17 03:40 PM
MILLIGAN JOHN FPresident and COODec 07Option Exercise14.50100,0001,450,2501,129,108Dec 09 02:14 PM
MILLIGAN JOHN FPresident and COODec 07Sale103.18100,00010,317,9771,029,108Dec 09 02:14 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Option Exercise24.3010,000242,950141,422Dec 03 01:57 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Option Exercise26.992,00053,98050,783Dec 03 01:56 PM
MARTIN JOHN CChairman and CEODec 01Option Exercise14.50150,0002,175,3754,098,066Dec 03 01:57 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Sale106.382,000212,76048,783Dec 03 01:56 PM
MARTIN JOHN CChairman and CEODec 01Sale105.82150,00015,873,4673,948,066Dec 03 01:57 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Sale106.0112,0001,272,159129,422Dec 03 01:57 PM
Cogan John FrancisDirectorNov 24Option Exercise20.7115,000310,57559,309Nov 25 02:21 PM
Cogan John FrancisDirectorNov 24Sale105.9515,0001,589,19044,309Nov 25 02:21 PM
Whitley Richard JamesDirectorNov 24Sale106.4816917,99530,719Nov 25 02:22 PM
Whitley Richard JamesDirectorNov 23Sale107.182,863306,84530,888Nov 25 02:22 PM
Whitley Richard JamesDirectorNov 20Sale106.995,514589,91733,751Nov 25 02:22 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSONov 16Option Exercise23.7670,0001,662,850235,168Nov 18 12:32 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSONov 16Sale102.6570,0007,185,419165,168Nov 18 12:32 PM
MILLIGAN JOHN FPresident and COONov 09Option Exercise14.50100,0001,450,2501,129,108Nov 12 01:01 PM
MILLIGAN JOHN FPresident and COONov 09Sale107.66100,00010,765,6441,029,108Nov 12 01:01 PM
Washington Robin LEVP, CFONov 05Option Exercise0.006,000033,724Nov 09 05:41 PM
MARTIN JOHN CChairman and CEONov 02Option Exercise14.50150,0002,175,3754,098,066Nov 04 01:23 PM
Alton Gregg HEVP, Corp & Med AffairsNov 02Option Exercise24.3010,000242,950143,422Nov 04 02:41 PM
Carter Paul RutherfordEVP Commercial OpsNov 02Sale108.362,000216,71248,783Nov 04 04:27 PM
Washington Robin LEVP, CFONov 02Sale109.466,250684,15088,046Nov 04 04:21 PM
Alton Gregg HEVP, Corp & Med AffairsNov 02Sale109.3812,0001,312,507131,422Nov 04 02:41 PM
MARTIN JOHN CChairman and CEONov 02Sale109.42150,00016,413,0263,948,066Nov 04 01:23 PM
Cogan John FrancisDirectorOct 27Option Exercise20.7115,000310,57559,309Oct 28 08:13 PM
Cogan John FrancisDirectorOct 27Sale110.0015,0001,650,00044,309Oct 28 08:13 PM
Cogan John FrancisDirectorOct 26Option Exercise20.7115,000310,57559,309Oct 27 03:09 PM
Cogan John FrancisDirectorOct 26Sale110.0015,0001,650,00044,309Oct 27 03:09 PM
Carter Paul RutherfordEVP Commercial OpsOct 26Sale110.061,500165,09248,783Oct 28 02:51 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOOct 15Option Exercise23.6070,0001,652,248235,168Oct 16 05:32 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOOct 15Sale100.0570,0007,003,220165,168Oct 16 05:32 PM
MILLIGAN JOHN FPresident and COOOct 07Option Exercise14.50100,0001,450,2501,129,108Oct 08 02:06 PM
MILLIGAN JOHN FPresident and COOOct 07Sale99.22100,0009,921,5241,029,108Oct 08 02:06 PM
Alton Gregg HEVP, Corp & Med AffairsOct 05Option Exercise24.305,000121,475138,422Oct 07 01:22 PM
Alton Gregg HEVP, Corp & Med AffairsOct 05Sale100.005,000500,000133,422Oct 07 01:22 PM
MARTIN JOHN CChairman and CEOOct 01Option Exercise14.50150,0002,175,3754,098,066Oct 05 01:28 PM
Alton Gregg HEVP, Corp & Med AffairsOct 01Option Exercise24.305,000121,475140,422Oct 05 02:13 PM
Alton Gregg HEVP, Corp & Med AffairsOct 01Sale97.287,000680,930133,422Oct 05 02:13 PM
MARTIN JOHN CChairman and CEOOct 01Sale97.48150,00014,622,2893,948,066Oct 05 01:28 PM
Carter Paul RutherfordEVP Commercial OpsOct 01Sale98.592,000197,18048,783Oct 05 04:26 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOSep 15Option Exercise23.6070,0001,652,000235,168Sep 17 04:26 PM
Cogan John FrancisDirectorSep 15Option Exercise20.7115,000310,57559,309Sep 17 03:54 PM
Alton Gregg HEVP, Corp & Med AffairsSep 15Option Exercise24.305,000121,475140,422Sep 17 03:55 PM
Alton Gregg HEVP, Corp & Med AffairsSep 15Sale110.005,000550,000135,422Sep 17 03:55 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOSep 15Sale110.7070,0007,749,195165,168Sep 17 04:26 PM
Cogan John FrancisDirectorSep 15Sale110.0015,0001,650,00044,309Sep 17 03:54 PM
MILLIGAN JOHN FPresident and COOSep 08Option Exercise14.50100,0001,450,2501,129,108Sep 10 02:57 PM
MILLIGAN JOHN FPresident and COOSep 08Sale103.39100,00010,338,7301,029,108Sep 10 02:57 PM
Washington Robin LEVP, CFOSep 02Sale102.206,250638,77894,296Sep 03 03:07 PM
Alton Gregg HEVP, Corp & Med AffairsSep 01Option Exercise24.2210,000242,208147,422Sep 03 03:06 PM
Alton Gregg HEVP, Corp & Med AffairsSep 01Sale102.7512,0001,233,008135,422Sep 03 03:06 PM
WILSON GAYLE EDirectorAug 28Option Exercise20.7180,0001,656,400122,769Aug 31 06:17 PM
WILSON GAYLE EDirectorAug 28Sale106.9621,0002,246,160101,769Aug 31 06:17 PM
V Visa Inc. daily Stock Chart
Visa Inc.
IndexDJIA S&P500 P/E30.36 EPS (ttm)2.57 Insider Own0.06% Shs Outstand2.35B Perf Week-2.33%
Market Cap183.53B Forward P/E23.56 EPS next Y3.31 Insider Trans-2.95% Shs Float1.90B Perf Month1.71%
Income6.84B PEG2.08 EPS next Q0.73 Inst Own93.60% Short Float2.57% Perf Quarter1.23%
Sales14.28B P/S12.85 EPS this Y19.50% Inst Trans-0.07% Short Ratio5.46 Perf Half Y5.17%
Book/sh11.37 P/B6.87 EPS next Y18.87% ROA- Target Price90.53 Perf Year2.92%
Cash/sh3.72 P/C20.97 EPS next 5Y14.61% ROE- 52W Range59.67 - 81.71 Perf YTD1.02%
Dividend0.56 P/FCF60.51 EPS past 5Y30.70% ROI21.40% 52W High-4.48% Beta0.86
Dividend %0.72% Quick Ratio1.80 Sales past 5Y11.50% Gross Margin- 52W Low30.81% ATR1.39
Employees11300 Current Ratio1.80 Sales Q/Q3.20% Oper. Margin52.80% RSI (14)50.44 Volatility1.69% 1.64%
OptionableYes Debt/Eq0.48 EPS Q/Q-75.70% Profit Margin- Rel Volume0.87 Prev Close79.19
ShortableYes LT Debt/Eq0.48 EarningsJul 21 AMC Payout- Avg Volume8.94M Price78.05
Recom1.90 SMA200.94% SMA500.19% SMA2002.32% Volume7,768,576 Change-1.44%
Jul-22-16Reiterated Stifel Buy $86 → $91
Jun-06-16Resumed JP Morgan Overweight $88
Apr-20-16Reiterated Sun Trust Rbsn Humphrey Buy $85 → $100
Apr-15-16Initiated Compass Point Neutral $80
Feb-11-16Downgrade BofA/Merrill Buy → Neutral
Dec-17-15Initiated Sterne Agee CRT Buy
Dec-16-15Initiated UBS Buy $90
Nov-03-15Reiterated RBC Capital Mkts Outperform $82 → $91
Oct-22-15Resumed Wells Fargo Outperform
Oct-19-15Reiterated Oppenheimer Outperform $81 → $85
Aug-20-15Reiterated Barclays Overweight $80 → $85
Jul-24-15Reiterated Topeka Capital Markets Hold $66 → $70
Jul-24-15Reiterated RBC Capital Mkts Outperform $79 → $82
Jul-24-15Reiterated FBR Capital Mkt Perform $70 → $80
Jul-20-15Reiterated Oppenheimer Outperform $73 → $81
Jul-14-15Reiterated Bernstein Outperform $77 → $81
May-20-15Initiated Credit Agricole Outperform $77
Jan-30-15Reiterated Stifel Buy $280 → $308
Jan-30-15Reiterated Argus Buy $295 → $300
Jan-30-15Downgrade FBR Capital Outperform → Mkt Perform $260
Jul-29-16 02:28PM  MasterCard Doesnt Think Visa and PayPal Are In An Exclusive Relationship at Fortune
01:04PM  VISA INC. Financials
11:43AM  Dow 30 Stock Roundup: Apple, GE, DuPont Beat, Boeing Posts Narrower-than-Expected Loss
08:58AM  Post Earnings Coverage as MasterCard Tops Market Expectation on Increased Card Spending
08:08AM  On BizWireTV: Cybercrime Meets Its Match and the Importance of Checking Your Credit Score Business Wire
Jul-28-16 04:06PM  MasterCard 2Q Revenue Growth Compelling Despite Global Concerns
12:39PM  Credit-card issuers are ditching foreign transaction fees to attract big spenders at MarketWatch
11:04AM  How Visas Valuation Was Impacted by Visa Europe Buy
10:49AM  MasterCard Jumps On Q2 Beat, Expects Minimal '16 Brexit Impact
10:47AM  These 4 Credit Cards Have The Most Fees
09:04AM  Visas Data Processing Expands on International Growth
08:16AM  What You Need to Know About the Costco Visa Card at Motley Fool
Jul-27-16 03:50PM  4 Stocks to Watch Before the Market Opens Tomorrow
11:05AM  How Visas Operating Profit Margins Beat Its Competitors
09:07AM  Visas International Volume Grows on Stable Dollar in Fiscal 3Q16
Jul-26-16 11:15AM  PayPal CEO on Visa partnership
11:06AM  Why Investors Reacted Negatively to the PayPal-Visa Deal
09:07AM  Visa Manages to Lower Expenses in Fiscal 3Q16
09:04AM  Why American Express Valuations Rose Marginally
03:25AM  Millennium Posts Best Quarter in 11 Years on Gain From Visa Deal at Bloomberg
Jul-25-16 04:44PM  Yahoo-Verizon, AMC-Carmike Headline 5 Big M&A Deals Monday
04:16PM  VISA INC. Files SEC form 10-Q, Quarterly Report
02:06PM  [$$] Visa, MasterCard Make Deals to Get Paid at
12:49PM  Brexit Not Deterring Expectations for Visa Europe
12:49PM  Visa Beats 3Q Estimates on Increased Spending
11:04AM  Amex Yields and Repurchases Rise to Restore Confidence
10:10AM  Company News for July 25, 2016
10:00AM  Why It's OK That Visa's Q3 Profit Dove by 76% at Investopedia
09:05AM  Amexs Global Network and Merchant Services in Q2
09:04AM  MasterCards Growth, Dividends Attractive to Long-Term Investors
08:47AM  Visa to Open New Silicon Valley Office Business Wire
Jul-24-16 12:56PM  Reiterating Our $50 Fair Value Estimate on PayPal
Jul-23-16 08:22AM  Better Buy: Visa Inc vs. Paypal Holdings Inc at Motley Fool
Jul-22-16 04:39PM  Who Got Best Of Visa-PayPal Deal? 'Too Early To Tell'
04:01PM  Visa, Amex Push Dow Higher Friday at 24/7 Wall St.
03:28PM  ETFs with exposure to Visa, Inc. : July 22, 2016
03:14PM  Wells Fargo Cuts PayPal To Hold On Visa Deal at
02:52PM  Stocks Hold Gains Despite Disappointing Earnings
02:25PM  Trending Tickers: SKX, V, PYPL, GE, CMG
01:43PM  PayPal (PYPL) and Visa Partnership 'A Phenomenal Move,' Wedbush's Luria Tells CNBC
01:15PM  Why American Expresss Global Commercial Services Rose
01:15PM  Why American Expresss International Business Is Rising
01:11PM  Mergers and Marketing Efforts Pressure MasterCards Margins
01:11PM  MasterCard Targets Groceries, Wearable Payment Systems for Growth
01:11PM  International Business Is Key to MasterCards Continued Growth
01:11PM  MasterCard Deploys Leverage for Inorganic Expansions
12:52PM  PayPal Shares Fall on Concern Visa Deal Will Hit Profit Margins at Bloomberg
11:52AM  Pandora, PayPal, Visa, and Other Stocks in Spotlight on Friday at Insider Monkey
11:26AM  Paypal, Visa announce strategic partnership
10:55AM  Stocks Turn Higher as Wall Street Overlooks Earnings Disappointments
10:50AM  Visa, American Express Earnings: Key Highlights
10:48AM  Visa and PayPal finally working things out
10:44AM  PayPal Falls But Analysts Applaud Visa Partnership at
10:40AM  Why the PayPal and Visa Partnership Is a Great Idea at 24/7 Wall St.
10:33AM  Visa (V) Q3 Earnings Beat, Revenues in Line with Estimates
10:04AM  Dow industrials struggle to rebound after ending win streak at MarketWatch
09:30AM  The Zacks Analyst Blog Highlights: Starbucks, AT&T, Chipotle, Visa and Paypal
09:27AM  Stocks to Watch: GE, Honeywell, Whirlpool, Starbucks, Visa at The Wall Street Journal
08:56AM  Stock Futures Rise on Positive Earnings From GE, Visa
08:08AM  On BizWireTV: The Business of the Olympics - Brands Go For Gold and Take Over the Wire #Rio2016 Business Wire
08:05AM  U.S. stocks poised for a return to winning ways
07:15AM  Consumers win as Visa and PayPal go from enemies to ... frenemies? at MarketWatch
06:57AM  5 Things You Must Know Before the Market Opens Friday
04:09AM  Windsurfer Sonia Lo Becomes the Only Team Visa Athlete from Hong Kong PR Newswire
02:16AM  Edited Transcript of V earnings conference call or presentation 21-Jul-16 9:00pm GMT
Jul-21-16 06:47PM  [$$] PayPal and Visa ink partnership agreement at Financial Times
06:41PM  Visa profit tops estimates on higher payments volume
06:38PM  PayPal and Visa End Battle: Inside Their New Partnership
06:09PM  After The Close: Visa, Starbucks, Chipotle, Skyworks, PayPal, Silicon Motion Earnings
05:45PM  Visa earnings fall due to costs tied to Visa Europe purchase
05:45PM  Starbucks Stock Retreats but Portfolio Managers See Opportunity
05:37PM  PayPal, Visa Bury Hatchet; Visa EPS Beats, PayPal's Meets
05:19PM  PayPal And Visa Make Nice at Fortune
05:14PM  Visa profit tops estimates; sets $5 billion buyback
04:33PM  Visa shares flat after earnings beat at MarketWatch
04:29PM  Stocks Take Break As Earnings Roll In; How Did Chipotle, Starbucks Fare?
04:25PM  Visa profit drops, sets $5 bln buyback
04:24PM  Visa bottom line, PayPal top line beats
04:22PM  Visa, PayPal strike partnership in digital payments at MarketWatch
04:20PM  Visa (V) Stock Slides in After-Hours Trading on Q3 Revenue Miss
04:18PM  PayPal beats on second-quarter revenue, announces partnership with Visa at MarketWatch
04:12PM  VISA INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:06PM  Visa Inc. Reports Fiscal Third Quarter 2016 Results and Announces a New $5.0 Billion Share Repurchase Program Business Wire
04:05PM  PayPal and Visa End Battle, Unveiling Pact on Fees and Data at Bloomberg
04:04PM  PayPal and Visa Enter Partnership to Extend Consumer Payment Choice Business Wire
02:44PM  What to look for in Visa earnings at MarketWatch
02:42PM  AmEx Could Face More Hurt After Losing Costco
01:30PM  Why Amexs US Consumer Service Revenues Fell in Q2
01:30PM  Warren Buffett Seems to be Right on Amex: Q2 Results
12:39PM  As Credit Card Landscape Changes, Losing Costco Could Be Costly for AmEx
09:56AM  Behind AmEx's Q2 Profit Surge Lies a Big Problem at Investopedia
09:10AM  Is it Time to Buy This Credit Card Company
09:01AM  Post Earnings Coverage as American Express Earnings Jump 37 Percent
07:07AM  Q3 2016 Visa Inc Earnings Release - After Market Close
07:00AM  PayPal May Unveil Accord With Visa on Data Sharing, Analysts Say at Bloomberg
04:06AM  Why Is Citigroup Banking on Its Cards Business?
Jul-20-16 11:07PM  Visa Earnings Coming Up: What to Expect? at Investopedia
05:52PM  AXP reverses, turns lower
05:21PM  American Express 2Q earnings jump, helped by Costco sale
04:44PM  PayPal Earnings On Tap Amid Visa Speculation, Apple Competition
Visa Inc., a payments technology company, operates an open-loop payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions; and offers fraud protection for account holders and assured payment for merchants. The company also provides a suite of digital, ecommerce, person-to-person payments, and mobile products and services. In addition, it offers merchant gateway services for ecommerce merchants to accept, process, and reconcile payments; manage fraud; and safeguard payment security online, as well as processing services for participating issuers of visa debit, prepaid, and ATM payment products. The company provides its services under the Visa, Visa Electron, Interlink, and PLUS brands. Visa Inc. has a strategic alliance with Bottomline Technologies. The company was incorporated in 2007 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHEY ELLENVICE CHAIR RISK & PUB POLICYFeb 10Sale70.0039,3482,754,36049,996Feb 11 05:13 PM
PPG PPG Industries, Inc. daily Stock Chart
PPG Industries, Inc.
IndexS&P 500 P/E19.37 EPS (ttm)5.41 Insider Own0.40% Shs Outstand269.08M Perf Week-2.73%
Market Cap28.18B Forward P/E15.17 EPS next Y6.90 Insider Trans-7.50% Shs Float265.67M Perf Month2.17%
Income1.46B PEG2.08 EPS next Q1.74 Inst Own74.40% Short Float1.61% Perf Quarter-4.79%
Sales15.30B P/S1.84 EPS this Y30.50% Inst Trans0.05% Short Ratio2.87 Perf Half Y10.92%
Book/sh19.40 P/B5.40 EPS next Y10.71% ROA- Target Price123.94 Perf Year-2.11%
Cash/sh6.20 P/C16.88 EPS next 5Y9.33% ROE- 52W Range82.02 - 116.57 Perf YTD6.76%
Dividend1.60 P/FCF- EPS past 5Y17.20% ROI15.80% 52W High-10.17% Beta1.47
Dividend %1.53% Quick Ratio1.20 Sales past 5Y2.70% Gross Margin44.80% 52W Low27.66% ATR1.90
Employees46600 Current Ratio1.60 Sales Q/Q-0.90% Oper. Margin14.30% RSI (14)42.60 Volatility1.13% 1.44%
OptionableYes Debt/Eq- EPS Q/Q12.10% Profit Margin9.60% Rel Volume1.42 Prev Close105.48
ShortableYes LT Debt/Eq- EarningsJul 21 BMO Payout19.80% Avg Volume1.49M Price104.71
Recom1.80 SMA20-1.92% SMA50-2.08% SMA2001.47% Volume2,107,674 Change-0.73%
Jul-26-16Upgrade Seaport Global Securities Accumulate → Buy $125 → $130
Jun-23-16Upgrade Longbow Neutral → Buy
Mar-22-16Resumed Credit Suisse Outperform
Jan-22-16Reiterated Deutsche Bank Buy $110 → $105
Jan-05-16Initiated Seaport Global Securities Accumulate $115
Nov-25-15Reiterated RBC Capital Mkts Outperform $115 → $129
Oct-16-15Upgrade UBS Neutral → Buy $122
Oct-16-15Reiterated Barclays Equal Weight $120 → $115
Oct-12-15Upgrade Goldman Neutral → Buy $107 → $113
Sep-14-15Reiterated RBC Capital Mkts Outperform $126 → $115
Sep-08-15Reiterated RBC Capital Mkts Outperform $145 → $126
Jan-16-15Reiterated Argus Buy $238 → $271
Oct-17-14Reiterated RBC Capital Mkts Outperform $250 → $243
Oct-09-14Initiated RBC Capital Mkts Outperform $250
Jul-01-14Reiterated Deutsche Bank Buy $220 → $235
Apr-25-14Reiterated Argus Buy $216 → $224
Apr-21-14Reiterated Deutsche Bank Buy $213 → $220
Dec-06-13Reiterated Deutsche Bank Buy $195 → $210
Jul-22-13Reiterated UBS Neutral $148 → $156
Jul-22-13Reiterated RBC Capital Mkts Outperform $160 → $176
Jul-28-16 01:04PM  PPG INDUSTRIES INC Financials
11:04AM  Will PPG Industries 2Q Earnings Paint a Rosy Valuation Picture?
09:05AM  Will PPG Industries Glass Segment Cease to Exist in 3Q16?
06:00AM  Jim Cramer's Top Takeaways: Waste Management, Apple, PPG Industries, Centene
Jul-27-16 07:00PM  Cramer Remix: These stocks are the worst performers in the entire market at CNBC
11:07AM  PPG Industries Industrial Coatings Segment Topped Market Growth in 2Q16
09:10AM  Why PPG Industries 2Q16 Revenue from Performance Coatings Fell
Jul-26-16 11:34AM  Europe, China, and India Sales Rose, but Not Enough Not Help PPG Industries
11:34AM  How PPG Industries Managed to Miss Analysts 2Q16 Estimates
09:17AM  PPG Industries upgraded by Seaport Global Securities
08:29AM  PPG Industries, Inc. breached its 50 day moving average in a Bearish Manner : PPG-US : July 26, 2016
Jul-25-16 01:03PM  ETFs with exposure to PPG Industries, Inc. : July 25, 2016
Jul-22-16 01:04PM  Where Do Celanese Valuations Stand before Its 2Q16 Earnings Report?
12:39PM  PPG Industries, Inc. :PPG-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016
11:00AM  PPG INDUSTRIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements
Jul-21-16 06:09PM  Edited Transcript of PPG earnings conference call or presentation 21-Jul-16 6:00pm GMT
03:05PM  PPG Industries' Stock Stumbles as It Signals Times Are Changing
12:21PM  PPG INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition
12:17PM  PPG sells glass operations to Vitro SAB
10:07AM  [$$] PPG to Shed Flat-Glass Operations at The Wall Street Journal
10:02AM  PPG Directors Announce Quarterly Dividend of 40 Cents Per Share Business Wire
09:41AM  Healey Joins PPG Board of Directors Business Wire
09:01AM  PPG Industries (PPG) Beats on Q2 Earnings, Lags Revenues
09:01AM  Bunch to Retire as PPG Executive Chairman, CEO McGarry Elected to Succeed Business Wire
08:42AM  PPG Industries' (PPG) Q2 Earnings Beat, Sales Trail
08:40AM  Mexico's Vitro to buy flat glass unit of PPG for $750 mln
08:29AM  PPG Reaches Agreement with Vitro for Sale of Flat Glass Operations Business Wire
07:07AM  Q2 2016 PPG Industries Inc Earnings Release - Before Market Open
07:03AM  PPG Industries beats 2Q profit forecasts
06:51AM  PPG Reports Second Quarter 2016 Financial Results Business Wire
Jul-19-16 08:13AM  Chemical Stocks' Earnings to Watch This Week: PPG, SCL, SXT
Jul-18-16 09:48AM  Coverage Initiated on Select Specialty Chemicals Stocks
08:50AM  PPG Industries (PPG): Can Q2 Earnings Pull a Surprise?
Jul-16-16 11:04AM  Can Celaneses Operating Cash Flows Reach New Highs in 2Q16?
10:14AM  4 Ridiculously Cheap Dividend Stocks To Buy Now - And 1 To Sell at Forbes
Jul-14-16 05:29PM  PPG Industries (PPG) Launches Printable Label Stock, Teslin
03:56PM  Can Celanese Outperform Analysts Revenue Estimates in 2Q16?
10:06AM  Should SWK Investors Worry about the Lower Construction Spending?
Jul-13-16 02:37PM  PPG Foundation Donates $10,000 to Boys and Girls Clubs of Delaware for Science, Math Programs Business Wire
Jul-12-16 10:06PM  Can Eastmans Additives & Functional Products Segment Deliver?
06:04PM  How Will PPGs Performance Coatings Business Perform in 2Q16?
07:11AM  PPG Works with HUMANITARIUM Science Centre in Poland to Sponsor Interactive Laboratory of Colours Business Wire
Jul-11-16 03:38PM  PPG Announces Executive Appointment Business Wire
Jul-07-16 09:11AM  PPG Honors 10 Excellent Suppliers Business Wire
07:17AM  PPG Industries Wraps Up MetoKote Buy from Platinum Equity
Jul-06-16 08:11AM  PPG Completes Acquisition of Global Coatings Services Provider MetoKote Business Wire
Jul-05-16 03:05PM  Understanding PPGs Valuation Compared to Those of Peers
03:01PM  How 3M, PPG Will Be Impacted by US Construction Pullback
08:38AM  PPG Industries: Dassault Aviation OKs Aerocron E-coat Primer
Jul-04-16 07:46AM  PPG Receives FAA Approval to Repair Airbus Cockpit Windows
Jul-03-16 09:16AM  The Best Dividend Aristocrat Stocks To Buy at Motley Fool
Jun-30-16 05:20PM  Valspar Shareholders Approve Buyout by Sherwin-Williams
12:31PM  ETFs with exposure to PPG Industries, Inc. : June 30, 2016
12:06PM  Inside PPG Industries Glass Segment in 2Q16
07:24AM  PPG Signs Pension Transfer Agreement for 11,000 Retirees
Jun-29-16 04:43PM  PPG Industries Launches Glidden Diamond Interior Paint
03:24PM  PPG to Announce Second Quarter 2016 Results July 21 Business Wire
12:06PM  How Is PPGs Industrial Coatings Segment Holding Up?
Jun-28-16 01:41PM  PPG Industries, Inc. :PPG-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016
01:28PM  What Are Analysts Projecting for PPG Industries Revenue Growth in 2Q16?
01:28PM  Whats the Word among Analysts on PPG Industries?
11:07AM  MetLife Strikes Pension Buyout Deal With PPG
10:11AM  PPG Foundation Awards More Than $290,000 Through National Merit Scholarship Program Business Wire
09:48AM  MetLife, Massachusetts Mutual to Protect PPG Pension Risk
09:02AM  PPG Introduces GLIDDEN DIAMOND Interior Paint Business Wire
09:00AM  MassMutual Signs Pension Transfer Agreement with PPG PR Newswire
08:22AM  PPG to Transfer Pension Obligations to Insurance Companies
Jun-27-16 05:22PM  MetLife, MassMutual Win $1.6 Billion Pension Deal With PPG at Bloomberg
04:48PM  PPG INDUSTRIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
04:33PM  PPG to Transfer Pension Administration and Obligations to Massachusetts Mutual Life Insurance Company and Metropolitan Life Insurance Company Business Wire
04:25PM  PPG Industries, Inc. Value Analysis (NYSE:PPG) : June 27, 2016
02:02PM  Brexit fears deal heavy blow to chemical stocks at CNBC
01:12PM  PPG Announces Executive Appointment Business Wire
08:14AM  Trader doubles bearish position in PPG
Jun-24-16 05:57PM  PPG Industries' Enviro-Prime Epic E-coat Gets Approval -7.63%
10:06AM  Will Q3 Earnings Hold a Surprise for Monsanto (MON) Stock?
09:06AM  PPG Industries, Inc. breached its 50 day moving average in a Bullish Manner : PPG-US : June 24, 2016
Jun-23-16 08:47AM  PSA Group Gives Full Approval to ENVIRO-PRIME EPIC Electrocoat by PPG Business Wire
08:00AM  PPG Helps to Refurbish Associació de Solidaritat i Ajuda Veïnal Center with Volunteers, Donated Paint and Supplies Business Wire
Jun-22-16 02:00AM  PPG Donates More Than $12,000 to Support Child-Focused Programs in Two Russian Communities Business Wire
Jun-21-16 08:18AM  PPG Industries to Jettison European Fiber Glass Business
Jun-20-16 10:34AM  PPG Completes COLORFUL COMMUNITIES Project in Shanghai Business Wire
03:19AM  PPG Signs Agreement for Sale of European Fiber Glass Operations to Nippon Electric Glass Business Wire
Jun-17-16 06:54AM  PPG's Velvecron SR Coating to Protect Devices from Stains
Jun-16-16 10:11AM  PPG Named by IDG's Computerworld to 2016 List of 100 Best Places to Work in IT Business Wire
07:07AM  PPG Completes $10 Million Coatings Center in Tianjin, China
05:00AM  PPG Again Supports Annual Hands-On Science and Technology Exhibition for Children in Gonfreville Business Wire
Jun-15-16 01:43PM  PPG Hosts Meeting with Securities Analysts near Pittsburgh Business Wire
08:11AM  PPG Marks Completion of $10 Million Coatings Center of Excellence in Tianjin, China Business Wire
07:59AM  PPG Industries Well Placed on Acquisitions & Cost Actions
Jun-14-16 10:37AM  PPG Paint Manufacturing Facility in Huron Recognized for Recycling Program Business Wire
10:11AM  PPG Manufacturing Facility in Delaware Recognized for Recycling Program Business Wire
09:02AM  Violet Verbena Named 2017 Color of the Year by PPG PAINTS Brand Business Wire
Jun-13-16 08:26AM  PPG Industries, Inc. breached its 50 day moving average in a Bearish Manner : PPG-US : June 13, 2016
Jun-10-16 03:42PM  PPG Industries, Inc. (PPG): Dividends Since 1899 (& More Growth Ahead) at Insider Monkey
01:33PM  Dividends Since a899 (and More Growth Ahead)
01:32PM  PPG INDUSTRIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:11AM  PPG Fully Funds Its Share of Pittsburgh Corning Asbestos Trust Business Wire
Jun-09-16 11:19AM  PPG Donates $5,000 to United Way of Greater Moncton and Southeastern New Brunswick Business Wire
09:24AM  PPG Industries (PPG) to Buy MetoKote from Platinum Equity
PPG Industries, Inc. manufactures and distributes coatings, specialty materials, and glass products. It operates in three segments: Performance Coatings, Industrial Coatings, and Glass. The Performance Coatings segment provides coatings products for automotive and commercial transport/fleet repair and refurbishing; light industrial and specialty coatings for signs; coatings, sealants, and transparencies for commercial, military, regional jet and general aviation aircraft, and transparent armor for specialty applications; and chemical management services. This segment also offers protective and marine coatings and finishes for the protection of metals and structures to metal fabricators and heavy duty maintenance contractors, as well as to the manufacturers of ships, bridges, and rail cars; architectural coatings used by painting and maintenance contractors, and consumers for decoration and maintenance of residential and commercial building structures; and purchased sundries to painting contractors and consumers. The Industrial Coatings segment provides adhesives and sealants for the automotive industry; metal pretreatments and related chemicals for industrial and automotive applications; precipitated silicas for tire, battery separator, and other markets; substrates used in radio frequency identification tags and labels, e-passports, drivers' licenses, and identification cards; organic light emitting diode materials for use in displays and lighting; optical lens materials and photochromic dyes for optical lenses and color-change products. The Glass segment produces flat and fiber glass for use in commercial and residential construction, wind energy, energy infrastructure, transportation, and electronics industries. The company was founded in 1883 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Option Exercise65.7630,4502,002,24069,044Jul 28 10:15 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Sale106.6440,9504,367,01428,094Jul 28 10:15 AM
USHER THOMAS JDirectorApr 20Option Exercise0.001,09202,092Apr 22 03:30 PM
RICHENHAGEN MARTINDirectorApr 20Option Exercise0.001,092020,576Apr 22 03:25 PM
HOOPER MICHELE JDirectorApr 20Option Exercise0.001,092015,352Apr 22 03:16 PM
Sklarsky Frank SExecutive VP & CFOFeb 29Option Exercise0.0010,000024,467Mar 02 12:40 PM
BUNCH CHARLES EExecutive Chairman of BoardFeb 26Sale98.1746,2864,543,711732,911Mar 01 04:01 PM
RICHENHAGEN MARTINDirectorFeb 20Option Exercise0.001,750019,484Feb 23 08:44 AM
HOOPER MICHELE JDirectorFeb 20Option Exercise0.001,750014,260Feb 23 08:40 AM
BERGES JAMES GDirectorFeb 20Option Exercise0.001,750010,488Feb 23 08:20 AM
BUNCH CHARLES EExecutive Chairman of BoardNov 16Sale101.9416,2861,660,115720,070Nov 17 04:04 PM
NIEKAMP CYNTHIA ASr. VP, Automotive CoatingsOct 30Sale104.357,200751,33960,498Nov 03 01:02 PM
BUNCH CHARLES EExecutive Chairman of BoardOct 26Sale103.7512,0001,244,952736,356Oct 27 04:03 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentOct 19Option Exercise55.0111,916655,49940,178Oct 20 09:11 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentOct 19Sale100.9811,9161,203,27828,262Oct 20 09:11 AM
BUNCH CHARLES EChairman and CEOAug 07Sale103.9612,7161,321,910748,356Aug 10 01:29 PM
HON Honeywell International Inc. daily Stock Chart
Honeywell International Inc.
IndexS&P 500 P/E18.88 EPS (ttm)6.16 Insider Own0.10% Shs Outstand782.22M Perf Week0.62%
Market Cap91.00B Forward P/E16.04 EPS next Y7.25 Insider Trans-53.63% Shs Float761.33M Perf Month1.63%
Income4.84B PEG2.21 EPS next Q1.72 Inst Own77.40% Short Float0.77% Perf Quarter2.33%
Sales38.89B P/S2.34 EPS this Y13.30% Inst Trans0.04% Short Ratio2.12 Perf Half Y13.95%
Book/sh24.59 P/B4.73 EPS next Y8.92% ROA10.00% Target Price126.12 Perf Year12.80%
Cash/sh8.91 P/C13.05 EPS next 5Y8.55% ROE27.00% 52W Range85.56 - 120.02 Perf YTD13.55%
Dividend2.38 P/FCF37.08 EPS past 5Y19.40% ROI16.00% 52W High-3.07% Beta1.12
Dividend %2.05% Quick Ratio0.70 Sales past 5Y3.60% Gross Margin30.70% 52W Low35.96% ATR1.78
Employees129000 Current Ratio1.30 Sales Q/Q2.20% Oper. Margin- RSI (14)48.88 Volatility1.34% 1.27%
OptionableYes Debt/Eq0.75 EPS Q/Q7.40% Profit Margin12.70% Rel Volume1.06 Prev Close115.76
ShortableYes LT Debt/Eq0.51 EarningsJul 22 BMO Payout26.80% Avg Volume2.76M Price116.33
Recom1.90 SMA20-0.97% SMA500.37% SMA2008.17% Volume2,939,758 Change0.49%
Apr-25-16Reiterated Stifel Buy $127 → $129
Apr-25-16Reiterated RBC Capital Mkts Outperform $121 → $122
Apr-18-16Reiterated Barclays Overweight $107 → $122
Feb-01-16Reiterated Stifel Buy $106 → $113
Dec-17-15Reiterated Oppenheimer Outperform $117 → $120
Nov-16-15Reiterated Barclays Overweight $103 → $104
Oct-20-15Reiterated Argus Buy $115 → $118
Oct-19-15Reiterated RBC Capital Mkts Outperform $121 → $120
Jul-31-15Reiterated Barclays Overweight $120 → $118
Jul-29-15Reiterated Barclays Overweight $115 → $120
Jul-21-15Reiterated Argus Buy $115 → $118
Jul-20-15Reiterated Stifel Buy $116 → $120
Jul-20-15Reiterated RBC Capital Mkts Outperform $116 → $122
May-15-15Reiterated Cowen Outperform $112 → $116
Jan-27-15Reiterated Argus Buy $106 → $115
Jan-22-15Initiated UBS Neutral $105
Dec-16-14Reiterated Stifel Buy $109 → $112
Nov-25-14Reiterated RBC Capital Mkts Outperform $105 → $116
Sep-17-14Resumed Stifel Buy $112
May-29-14Reiterated Oppenheimer Outperform $103 → $110
Jul-29-16 04:11PM  Better-than-Expected 2Q16 Operations Propel United Technologies
02:28PM  Industrial Q2 Results Fail to Lift ETFs
01:35PM  ETFs with exposure to Honeywell International, Inc. : July 29, 2016
10:43AM  Honeywell Declares Quarterly Dividend PR Newswire
10:22AM  Economic growth is anemic
09:06AM  General Electrics 2Q16 Revenues Better than Expected
Jul-28-16 04:59PM  Honeywell To Present At Jefferies Industrials Conference PR Newswire
03:15PM  Why Roper Technologies Fell Short of Market Expectations in 2Q16
11:04AM  How Honeywell Is Addressing Brexit Concerns
09:05AM  Does Honeywells 3Q16 Guidance Spell Disaster?
Jul-27-16 03:54PM  Key Takeaways from 3Ms 2Q16 Sales Performance
03:53PM  3M in 2Q16: Improving Operations Mask Underlying Demand Weakness
02:01PM  Top 7 Research Reports for July 27, 2016
01:36PM  Mario Gabelli Comments on Honeywell International Inc.
01:17PM  The Gabelli Value 25 Fund 2nd-Quarter Shareholder Commentary
01:00PM  Lower Volumes Still Impacted Lincoln Electrics Revenues in 2Q16
01:00PM  How Did Lincoln Electric Meet Its Earnings Forecast for 2Q16?
11:05AM  Why This HON Segments Performance Was Better Than You Think
10:00AM  DFNDR Armor Selects Honeywell Spectra® Material for New Military and Law Enforcement Body Armor PR Newswire
09:57AM  Turkish Refiner Tupras Using Honeywell UOP Unicracking Technology To Boost Diesel Production PR Newswire
09:07AM  Why HON Split Automation and Control Solutions into 2 Parts
09:00AM  NCFI Adopts Honeywell's Low-Global-Warming Material For Integral Skin Polyurethane Foam Systems PR Newswire
Jul-26-16 02:14PM  3 Takeaways From Honeywell International's Q2 Earnings at Motley Fool
02:01PM  A High Five United Technologies at Bloomberg
11:08AM  Analyzing Honeywell Aerospaces Strengths, Weaknesses
10:11AM  Honeywell International, Inc. :HON-US: Earnings Analysis: Q2, 2016 By the Numbers : July 26, 2016
09:14AM  3M (MMM) Meets Q2 Earnings Estimates, Trims 2016 View
09:07AM  Defense a Key Sales Driver in Honeywells Aerospace Segment
Jul-25-16 07:25PM  See which big Arizona employer shows up in Wikileaks DNC emails at
07:01PM  Cramer: Dem, GOP Platforms Both Hurt Stocks
05:31PM  Business Jets in Focus Ahead of General Dynamics, Raytheon Earnings
02:00PM  Honeywell Sales Grounded by Weak Aerospace Results in 2Q16
02:00PM  Weak Industrial Demand a Cause for Honeywell Shares to Retreat
12:22PM  Honeywell's Future Looks Less Than Sweet
11:37AM  How Did Boeings Key Indicators Perform in 2Q16?
10:10AM  Stock Market News for July 25, 2016
10:05AM  Is Honeywell Priming for a Breakup? at Bloomberg
09:33AM  Honeywell (HON) Stock Slides, Barclays Ups Price Target
09:13AM  Honeywell's Going Down a Path of No Return at Motley Fool